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EPIDEMIOLOGY OF CAMPYLOBACTER JEJUNI
Abstract
A study was conducted to determine the prevalence of 
Campylobacter jejuni in various avian species and humans.
Cloacal swabs derived from birds submitted to the 
Louisiana Veterinary Medical Diagnostic Laboratory for
necropsy examination during the period February 1987
through July 1 988 were routinely cultured for C^ _ jejuni 
using Butzler's selective medium. Campylobacter jejuni was 
isolated from 10.1% of the cases examined. The isolation 
rate was 25.2% in Galliformes, 12.9% in Anseriformes, 8.3% 
in Columbiformes, 7.7% in Falconiformes, and 0.6% in
Psittaciformes. None of the other orders of birds examined 
yielded C^ _ j ej un i. Prevalence data demonstrated that
Galliformes are important reservoirs of jejuni infection 
for humans and that Psittacines do not represent any
significant risk to human contacts.
Prevalence of C^ _ jejuni in diarrheic patients was 
studied during a one-year period, from August 1987 through 
July 1988. Of a total 1423 fecal samples cultured, 38 
yielded C^ jejuni giving an isolation rate of 2.7%. This
is comparable to the 2.6% prevalence rate obtained in a 
similar study in Texas. Prevalence rate for Salmonella 
spp. during the same study was 2.0%. Seasonal fluctuation 
in prevalence of C_._ jejuni in humans was demonstrated, with 
a peak in Summer and a smaller increase in Winter. A high 
incidence was observed in children under 5 years, and in 
adults aged 21 to 25 and 31 to 40 years.
The Penner serotyping system was able to classify 
91.1% of the isolates obtained from human patients and 
96.7% from avian species. Fourteen of the 16 serotypes 
considered in the present study were identified among the 
isolates. Eight of the serotypes were common to both avian 
species and humans indicating the potential for zoonotic 
transmission of Cj_ jejuni infection from birds. Serotype 
Penner 1 was isolated only from avian species indicating 
the low risk this serotype poses for humans while serotype 
Penner 10 was isolated mainly from humans suggesting that 
this serotype is transmitted by direct contact or acquired 
from non-avian species.
Two serotypes (Penner 5 and 10) showed consistent 
production of enterotoxins. Toxin was produced by 75% of 
human and 85% of avian isolates demonstrating the 
considerable potential for human infection with toxigenic 
strains of jejuni.
viii
EPIDEMIOLOGY OF CAMPYLOBACTER JEJUNI
Chapter 1 
INTRODUCTION
Campylobacteriosis has received considerable attention 
as a food-borne zoonosis during the past decade (Butzler 
and Skirrow, 1979; Blaser et al., 1979; Shane and 
Montrose, 1985). Recovery of Campylobacter jejuni from 
human cases of enterocolitis has stimulated investigation 
of the epidemiology and pathogenesis of the disease (Drake 
et al. , 1981; Coffin et al., 1982). The pathogen occurs 
frequently in the intestinal tract of food animals 
(Prescott and Munroe, 1982; Garcia et al., 1983), 
including cattle (Prescott and Bruin-Mosch, 1981), sheep 
(Bolton et al., 1982), goats (Firehammer and Myers, 1981) 
and chickens (Simmons and Gibbs, 1979).
The role of animals as reservoirs of campylobacteriosis 
has been investigated since the recognition of the disease 
(King, 1957). Campylobacter jejuni infection may be 
transmitted by undercooked poultry (Brower et al., 1979),
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unpasteurized milk (Blaser et al., 1979 ), undercooked red 
meat (Yangisawa, 1980), seafood (Blaser, 1982) and 
untreated surface water (Vogt et al., 1982). Prolonged 
survival of the organism in contaminated meat, even when 
stored at low temperatures (Yogasundram and Shane, 1986), 
increases the probability of food-borne infection.
The development of selective media for the isolation of 
£' 7ejvni in the early 1980's, facilitated research and 
investigation of outbreaks of campylobacteriosis. Blaser 
(1982) reported that C. jejuni is isolated as a primary 
pathogen from humans more frequently than either 
Salmonella spp. or Shigella spp. Many hospitals and 
health care facilities now routinely screen feces from 
diarrheic patients for Campylobacter spp.
Isolation of C. jejuni from clinical cases has been 
reported from most industrialized and third world 
countries (Table 1).
The average length of 
infection 
Salmonella 
(Harris 
frequently 
(6.7% cases)
illness following C. jejuni 
in contrast to infection with 
be 5 to 12 days in duration 
Hospitalization was more 
treat campylobacteriosis
is 11 to 17 days 
spp. which may 
et al., 1986). 
required to 
than for Salmonellosis (3.5%).
Table 1. Isolation of C. jejuni from diarrheic human 
patients.
Country Reported by Year Prevalence
Q.
”6
Australia Steele and McDermott 1976 5.8
Britain Bruce et al 1977 13.9
Africa Demol and Bosman 1978 11.0
France Delorme et al 1979 9.0
Indonesia Ringertz et al 1980 4.8
United States Young et al 1980 4.7
Bangladesh Stoll et al 1982 14.0
India Nair et al 1983 10.0
Brazil Fernandez et al 1985 7.4
China Young et al 1986 11.8
I reland Lafong and Bamford 1986 2.0
The relative significance of the two infections is 
reflected in the estimated costs associated with 
salmonellosis and campylobacteriosis in the United States 
(Morrison and Roberts, 1986). The total annual cost 
attributed to campylobacteriosis in the US during 1985 was 
estimated to range from $ 720 million to $ 1.4 billion
depending on certain assumptions regarding the value of 
human life. The comparable figure for salmonellosis 
ranged from $ 670 million to $ 1.2 billion. The derivation 
of costs is provided in Table 2.
An estimated 2.1 million cases of campylobacteriosis 
occur in the United States annually, including 2,100 
fatalities (case fatality rate 1:1000). A study conducted 
in Seattle (1985) indicated that approximately 50% of the 
cases of campylobacteriosis were directly or indirectly 
associated with consumption of poultry. The annual costs 
attributed to poultry-related campylobacteriosis range 
from $ 350 million to $ 700 million, justifying research 
into methods of control and prevention.
Reduction or elimination of C. jejuni contamination in 
poultry and meat is an essential step in reducing losses 
due to campylobacteriosis. An estimated 1.8 million cases 
of salmonellosis and campylobacteriosis are attributable 
to consumption of beef and chicken (Menning, 1988). Due
Table 2. U.S. Costs for Campylobacteriosis, 1985
Costs Cases Total Estimate
Cost categories per case 
$ Number
$ in : 
Low
millions
High
Medical Costs
Mild cases 0 2,042,660
or
1,931,975
0 0
Moderate cases 
and deaths
938 57,340
168.025
53.8 157.6
Lost productivity
Mild cases 230* 2,042,660
or
1,931,975
469.8 444 . 4
Moderate cases 289** 55,340
or
166,025
16.0 48.0
Deaths:
Human capital method 
or
Adjusted human 
capital/willingness 
to pay
85,800
or
351,500
2,100 180.2 738.2
Miscellaneous*** 62 57,340
or
168,025
3.6 10.4
Total $723 to $ 1,399
* This productivity loss estimate for mild cases also 
includes some miscellaneous costs of undetermined value. 
** This is a low estimate because it omits the value of 
homemaking.
*** Miscellaneous costs include transportation, child 
care, laboratory tests, acquiring employment.
Source: Morrison and Roberts, 1986
to the high population density in commercial broiler and 
turkey farms, transmission of C. jejuni between and within 
flocks proceeds rapidly and contributes to high rates of 
prevalence (Prescott and Gellner, 1984; Annan-Prah and 
Jane, 1988). Transmission by flies and coprophagy 
facilitate the spread of C. jejuni infection (Shane et 
al., 1985). Although growing broilers on wire floors will 
theoretically reduce infection, this system is neither 
technically nor economically feasible. Biosecurity and 
surveillance will reduce, but not eliminate, infection and 
transmission of C. jejuni at the farm level.
Competitive inhibition as exemplified by the 'Nurmi 
Concept' involves the introduction of a complex of 
microorganisms from the intestinal tract of mature birds 
into newly hatched chicks to suppress infection with both 
C. jejuni and Salmonella spp. (Nurmi and Rantala, 1973). 
Though this procedure has shown promise in eliminating 
Salmonella infection, it has been shown to be inefficiant 
in eliminating C. jejuni (Shanker et al., 1988). 
Implementing this procedure on a commercial basis is 
impractical using existing technology (Hudson et al., 
1987 ) .
Antibiotics such as tetracycline in feed suppress 
bacterial infection and show an increase in weight gain 
for broilers. Under practical conditions, infection
re-occurs in flocks during the mandatory withdrawal period 
for antibiotics upto 5 days before depletion.
Cross contamination between broiler carcasses occurs in 
the processing plant (Luechtefeld et al., 1982). Studies 
indicate isolation of C. jejuni in 65% of carcasses at 
retail outlets (Hosie et al., 1982). This suggests that 
chlorination added to processing plant chill tanks is not 
effective in eliminating C. jejuni (Cruickshank, 1982). 
Low dose irradiation was demonstrated to be a more 
effective decontaminant, than chemicals (Yogasundram et 
al., 1987). A radurization dose of 1 KGy effectively 
eliminated C. jejuni surface contamination at a level of 
10 Colony Forming Units (CFU) per cm on chicken 
drumsticks. Subjecting poultry meat and seafood to low- 
dose irradiation after packing, represents an effective 
method of eliminating C. jejuni contamination.
Chapter 2
EPIDEMIOLOGY
Campylobacter jejuni is now accepted as a major cause 
of enterocolitis in humans (Skirrow, 1977). The 
prevalence of C. jejuni infection often relates to 
diagnostic dilligence and the thoroughness of laboratory 
procedures. The microaerophilic and thermophilic growth 
requirements of this organism demands special media and 
isolation techniques. The development of selective media, 
incubation at 42°C, and the use of commercial gas mixtures 
have contributed to an increased recovery rate of 
£ m jejuni from animals and man (Butzler and Skirrow, 
1979) .
The prevalence of intestinal campylobacteriosis is 
extensively documented and isolation from clinical cases 
has been recorded in many developed and third-world 
countries (Table 1). Recovery of C. jejuni from feces of 
diarrheic patients exceeds the isolation rate of 
Salmonella spp. (Harris et al., 1986a)
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Identification of C. jejuni in 8 to 13% of diarrheic 
patients in developing countries has been reported by 
Bokkenheuser and Sutter (1981) in contrast to only 4 to 7% 
from cases in industrialized countries. The corresponding 
recovery rates for C. jejuni from clinically unaffected 
individuals are 5 to 17% and 0 to 1% respectively in these 
two catogories.
The magnitude of the problem in developing countries is 
generally underestimated since the prevalence rate is a 
function of of C. jejuni isolation. With the exception of 
structured surveys, reports are limited in contrast to the 
situation in developed countries, where routine 
examination for Campylobacter spp. is undertaken and where 
national reporting system exist (Blaser et al.,1983a). The 
relatively high rate of recovery from clinically 
unaffected individuals in developing countries complicates 
an appraisal of the significance of C. jejuni in diarrheic 
patients ( Bokkenheuser and Sutter, 1981).
Blaser et al. (1980a) reported an isolation rate of 18% 
in children aged 1-5 years in rural Bangladesh. 
Aboriginal Australian children are healthy carriers of 
C. jejuni with an isolation rate of 17% according to Berry 
et al.(1981). Rajan and Mathan (1982) demonstrated a 15% 
prevalence in all ages of healthy individuals in Southern
India. Lower rates were reported in Ethiopia,(3%) (Thoren 
et al., 1982); Gambia,(4.2%) (Billingham, 1981); Zaire, 
(6%) (Butzler, 1978) and Central Africa (3%)(De Mol et 
al., 1980).
In developed countries, isolation of C. jejuni in feces 
is uncommon unless patients present with diarrhea. 
Several surveys indicated a prevalence of only 1% in 
clinically normal individuals. In Belgium, isolation from 
healthy individuals and diarrheic patients attained 1.3% 
and 5.1% respectively (Butzler et al., 1973). In England 
rates were 0.6% and 13.9% (Bruce et al., 1977); In the 
Netherlands 0% and 10.8% (Severin, 1978); France 0% and 9% 
(Delorme et al., 1979); and in The United States 1.2% and 
4.7%, (Young et al.,1980). Bruce et al. (1977) recovered
C. jejuni from 39 out of 280 patients with acute 
gastroenteritis in Hereford, England. In contrast, these 
authors recovered C. jejuni from only 2 out of 117 
contacts and only 1 out of 156 non-diarrheic patients. 
Drake et al. (1981), isolated C. jejuni from 63 of 1953 
fecal samples of diarrheic patients in the Mayo Clinic 
during 1979, in contrast to an isolation rate of 2% for 
Salmonella spp. and Shigella spp. combined. Goodman et 
al. (1981) examined 2059 fecal samples from hospital
patients and food handlers. A total of 26 were positive 
for C. jejuni and of these 96% showed acute diarrhea.
In Bangladesh, Stoll et al. (1982) recovered C. jejuni
from 14% of 3550 patients included in a survey of infants
and adults. Rajan and Mathan (1982), reported on the 
isolation of C. jejuni from 15% of a random sample of 
healthy individuals in Southern India. In contrast, Nair, 
Battacharya and Pal (1983) isolated C.jejuni from only 10% 
of the 116 acute cases of diarrhea admitted to an 
infectious disease hospital in Northern India. In half of 
these confirmed cases, C. jejuni was recovered in
conjunction with Vibrio cholera.
Seasonal fluctuation in the incidence of 
campylobacteriosis has been reported by many 
investigators. An epidemiological survey conducted in 
Texas on C. jejuni (Subramanyam et al., 1984) showed an 
isolation rate of 2.3% (41/1840) from the feces of
patients with diarrhea. An increase in positive 
isolations (40%) occured during spring. Higher isolation 
rates in the United States during summer months was 
reported by Goodman et al. (1981). Similarly, an increase 
in prevalence during summer was documented in Belgium 
(Lauwers, Deboeck and Butzler, 1978), in Switzerland 
(Graf, Schar and Heinzer, 1980) and in the Peoples 
Republic of China (Tang et al., 1984).
Studies have been conducted to analyse the age 
distribution of C. jejuni infection in humans. In an 
epidemiological survey in Bangladesh, Glass et al. (1983) 
reported the highest rates of C. jejuni recovery in 
healthy infants. An isolation rate of 32% was reported in 
children less than one year old while an overall isolation 
rate of 19% was attained by children under five years. 
Prevalence in diarrheic children less than 12 months old 
and under 5 years of age was 25% and 20% respectively.
In contrast, the prevalence in diarrheic patients over 5 
years old was only 6% and in healthy individuals 3%.
In a study involving 435 patients with campylobacter
enteritis in Sweden, Walder (1982) demonstrated two peaks 
in age distribution. The first included infants up to 5 
years old and the second comprised individuals aged 20-35 
years.
Abbott et al. (1984), documented an increase in
C. jejuni infection in infants proportional to age. No 
isolates were obtained from infants under 1 month of age. 
An isolation rate of 3% occured in the 1-12 month age 
group, 6% from 12-24 months, and 7% in children 2-5 years 
of age. Tang et al. (1984) reported that children from
10 days to 8 years of age were most frequently affected in 
the Peoples Republic of China.
A seroepidemiologic study conducted in England by 
Jones and Robinson (1981), indicated an occupational
component to C. jejuni infection. The study revealed 
significant titers in 27% and 68% of agricultural workers
employed in poultry and cattle abbattoirs respectively
compared to 2 to 5% in controls engaged in crop
production. Blaser et al. (1979) implicated occupational 
exposure in three patients with C. jejuni infection. One 
was employed as a meat inspector in an abattoir, a second 
was a worker in a poultry processing plant and the third 
was a child of an abattoir worker.
2:1. Prevalence in the United States
A multicenter study conducted in 1980/1981 by Blaser et
al. (1983a) showed a 4.6% prevalence of C. jejuni in the 
United States. A total of 8097 fecal specimens from 8 
hospital laboratories in the United States were examined 
during a 15 month period. In Comparison to C. jejuni, 
Salmonella spp. and Shigella spp. yielded prevalence rates 
of 2.3% and 1.0% respectively. Positive fecal cultures 
were more frequently identified when samples were obtained
within a 7-day period following onset of illness.
The prevalence of C. jejuni in 8 states is depicted in 
Table 3.
Table 3. Isolation of Enteric Pathogens From Feces
State Specimens Specimens positive for
Studied Campylobacter Salmonella Shigella Any of 
the Three
n %
Michigan 636 9.3 1.7 0.5 11.5
Maryland 573 1.4 7.9 o « VO 10.2
Illinois 2947 6.7 2.4 0.3 9.4
Georgia 160 2.5 2.5 4.4 9.4
Colorado 352 6 . 0 1. 4 0.9 8.3
Oregon 797 5.6 1.8 0.8 8.2
Oklahoma 751 I-4 • to 2.0 4.3 7.5
California 1315 2.1 1.3 1.0 4.4
Source: Blaser et al., 1983.
Campylobacter jejuni was isolated from 8282 patients in 
42 states in the United States during the period January 
to December 1983 (Riley and Finch, 1985). These authors 
reported the highest frequency from infants (18/100,000 
population) and the lowest rate (3/100,000) from subjects 
over 55 years of age. Isolation was highest during summer 
with 46% of the isolates during the period June through 
September. Of the 9 geographical regions studied, the New 
England region (Maine, Massachussettes, New York) showed 
the highest isolation rate (20.8/100,000) while the West 
South Central region (Texas, Oklahoma, Arkansas,
Louisiana) showed the lowest isolation rate (0.3/100,000), 
as recorded in Figure 1 and Table 4.
Tauxe et al. (1987), in a study conducted in 1984,
reported 8837 C. jejuni isolations and 8 outbreaks of
campylobacteriosis. A national isolation rate of
4.9/100,000 population was recorded. As in the earlier 
studies, infants showed the highest infection rates 
(11/100,000) followed by adults aged 25 to 29 years. 
There was seasonal fluctuation, with a higher incidence 
during summer. In the Northeast and Southeast there was a 
peak commencing in June and extending through mid 
September followed by a second smaller peak in November. 
In the west, the summer peak occurred approximately one 
month earlier than the corresponding peaks in the 
Northeast and Southeast regions (Figure 2).
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Figure 2. Seasonal distribution of reported Campylobacter 
isolates by geographical region, United States, 
1984.
Source: Tauxe et a 1. , 1987
Table 4. Isolation of C. jejuni by geographic region
Region Prevalence per
100,000 population
New England 20.8
Pacific 13.9
Mid-Atlantic 11.9
South Atlantic 8.6
West North Central 8.2
Mountain 4.8
East North Central 3.2
East South Central 1.8
West South Central 0.3
Source: Riley and Finch, 1985
Chapter 3
SOURCE OF INFECTION
Many animal species have been recognized as carriers of 
C. jejuni representing a potential source of infection for 
humans (Smibert 1978; Skirrow 1982).
3:1. Avian species
Commercial poultry, and to a lesser extent free living 
avian species, are reservoirs of C. jejuni. Simmons and 
Gibbs (1979) isolated the organism from 72% of a batch of 
broilers delivered to a processing plant. Grant et 
al. (1980), isolated C. jejuni from 85% of cloacal swabs 
derived from live broilers in a market. Svedhem and 
Kaijser (1981) reported a recovery rate of 36% in broiler 
chickens. Smitherman et al. (1984) documented an 
isolation rate of 15% in cloacal swabs and feces obtained 
from four farms in California while Prescott and Gellner 
(1984) recovered C. jejuni from the colon of 28 out of 60 
chicken flocks reared on Canadian farms.
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The potential routes of entry of C. jejuni into a flock 
of chickens, include lateral infection of new-born chicks 
from older birds, indirect contact from fomites or 
contaminated feed and water (Blaser et al., 1983b). 
Generally there are no obvious signs of illness associated 
with intestinal carriage of C. jejuni by chicken 
(Ruiz-Palacios, 1983).
Prevalence rates in domestic poultry ranging from 30% 
to 100% have been reported by various workers: Bruce et
al. (1977) documented an isolation rate of 68% from a 
commercial chicken flock. Ribeiro (1978) recovered
C. jejuni from 31 out of 34 broilers. Goren and de Jong 
(1980) isolated C. jejuni from 30% of 239 chicken and 42% 
of 89 flocks of commercial broiler chickens. Grant et al.
(1980), recorded C. jejuni from 38 out of 46 rectal swabs 
obtained from live birds at a market. Isolation rates of 
up to 100% (Luechtefeld and Wang, 1980) have been obtained 
from fecal specimens from turkeys and 88% from sampling 
domestic ducks (Prescott and Bruin-Mosch 1981). C. jejuni 
was isolated from 35% of a small sample of free living 
ducks (Luechtefeld et al., 1980) and 8% of samples derived 
from non-domestic pigeons (Luechtefeld et al., 1981).
Harris et al. (1986b) reported isolation of C. jejuni 
from 57% of 297 broiler chicken carcasses at a processing
plant, 23% of 862 carcasses at point of sale and 17% of 29 
game-hen carcasses at a retail market. Contamination 
rates determined at regular intervals in the subject plant 
increased as the week progressed and a higher rate of 
recovery was obtained from samples collected later in the 
day. Eighty five percent of chicken livers and 89% of 
gizzards yielded C. jejuni in a study conducted by 
Christopher et al. (1982).
3:2. Companion animals
Companion animals, especially dogs and cats, can 
transmit C. jejuni to humans (Skirrow 1977; Blaser et al., 
1978; Vandenberghe et al., 1982). Hosie, Nicholson and 
Henderson (1979) identified C.jejuni in 11% of 179 canine 
fecal samples in Scotland but the authors did not detect 
any difference in isolation rate between diarrheic and 
non-diarrheic dogs and concluded that C. jejuni is not a 
primary pathogen in this species. Ferreira et al.,
(1979), in contrast reported a higher prevalence in 
diarrheic dogs (90%) compared to only 25% in clinically 
unaffected subjects. Blaser et al. (1978) implicated 
pups as a potential source of human campylobacteriosis. 
Wright (1982) isolated C. jejuni from 5% (12/260) of
canine fecal samples collected in a public park. Svedhem 
and Norkrans (1980) indicated that C. jejuni could be 
isolated from domestic cats and Patton et al. (1981) 
recorded a 14% prevalence in this species.
3:3. Cattle
Campylobacter jejuni is an intestinal commensal of 
cattle (Blaser et al.,1983b) and individual cows can 
excrete the organism in feces intermittently for several 
months (Robinson, 1982). Herds may be infected with 
multiple serotypes at any one time (Taylor et al., 1982). 
In a study conducted by these authors, one dairy herd 
yielded Penner serotypes 4,7,16 and 37, a second, Penner 
serotypes l,2and 7 while a third showed serotypes 7 and 
11. Bryner et al. (1972) recovered C. jejuni from 17% of 
bile samples derived from slaughtered beef cattle in Iowa.
Gill and Harris (1982) suggested that unweaned calves 
were more likely to serve as reservoirs of C. jejuni than 
mature cattle. In this study, a relatively high 
prevalence of 45% of fecal samples from unweaned calves 
yielding C. jejuni was attributed to cross contamination 
during transport and holding before slaughter.
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3:4. Swine
Swine may carry C. jejuni as an intestinal commensal 
(Luechtefeld and Wang, 1982). They reported 66% recovery 
of C. jejuni in 71 fecal samples collected from pig farms. 
Stern (1981) recorded an 87% (33/38) recovery rate from 
feces and a 22% (13/58) from carcasses at slaughter.
Similarly, in West Germany Sticht-Grah (1982) reported 
that 59% of herds were infected including 70% of fecal 
samples, 75% from ingesta and 45% from washed intestines. 
Intestinal tracts which were sampled before and after salt 
treatment yielded 50% and 42% respectively demonstrating 
only a small decrease in contamination. Slaughter 
equipment and the abattoir environment yielded 33% 
positive samples.
In a study of abattoirs and butcher's premises, Bolton 
et al. (1982), demonstrated that 56% of slaughtered pigs 
were intestinal carriers of C. jejuni. Svedhem and 
Kaijser (1981) reported a 95% prevalence rate in pigs 
sampled at slaughter.
3:5. Other animals
Zoo and laboratory animals can serve as a potential 
source of C. jejuni infection. Luechtefeld et al. (1981) 
documented C. jejuni in 6% of 575 fecal specimens derived 
from animals in a United States zoo. The organism has 
been isolated from clinically normal laboratory animals 
including hamsters, ferrets and rats (Fox, 1982). Among 
primates surveyed, baboons and two species of monkeys 
(Hacaca fascicularis, Erytrocibus patas) were found to be 
healthy carriers of C. jejuni with a prevalence rate of 
17.8% (Tribe et al., 1979).
Chapter 4
FOOD BORNE INFECTION 
4:1. Introduction
Outbreaks of campylobacteriosis ascribed to consumption 
of contaminated raw or undercooked food have been 
extensively documented (Blaser et al., 1983a). Poultry and 
red meat, unpasteurized milk, shellfish and other seafood 
have been implicated in outbreaks of campylobacteriosis. 
Poultry meat and raw milk are more frequently incriminated 
than other food items. This is consistent with studies 
which show that between 60% to 90% of packaged poultry 
meat are contaminated with C. jejuni (Luechtefeld and 
Wang, 1981; Kinde et al., 1983). Infection is associated 
with a high prevalence of C. jejuni in broilers reared on 
litter and the extent of cross contamination at various 
sites in poultry processing plants.
Certified raw milk is a potential source of C. jejuni 
infection. Infected cows may excrete the organism in 
milk which may also be contaminated by feces.
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4:2. Poultry as a source of infection
Poultry meat was initially suggested as a source of 
human campylobacteriosis by King (1962). Avian species 
serve as a productive host of C. jejuni (Prescott and 
Monroe, 1982) and the organism has been isolated from the 
intestinal tracts of chickens, turkeys, domestic ducks, 
migratory waterfowl, and free ranging pigeons. Studies 
have shown that commercial and backyard poultry are 
frequently infected with C. jejuni (Ribeiro, 1978). It is 
accepted that infection is acquired during the growing 
period and neither vertical transmission nor hatchery 
contamination occur (Oosterom, 1985). Campylobacte r 
jejuni could not be isolated from 850 samples derived from 
hatcheries, suggesting infection after placement of flocks 
(Oosterom and de Wilde, 1983). These workers also 
documented the isolation of C. jejuni from feces and 
litter after two to four weeks of rearing despite the fact 
that the day old chicks, feed, litter and environment of 
houses were negative for C. jejuni at the begining of the 
the investigation.
Demonstration of C. jejuni in cecal contents, meat and 
skin of broilers (Hayek and Cruickshank, 1977) and the
report by Bruce et al. (1977) concerning the similarity in 
biotype of chicken and human isolates has prompted 
investigations concerning the mode of transmission of 
C. jejuni from poultry to humans. Simon and Gibbs (1979) 
showed that C. jejuni present in the intestinal tract 
before slaughter could survive commercial processing. 
These authors isolated C. jejuni from the cecal contents 
of 36 out of 50 carcasses immediately after evisceration 
and subsequently at the end of the processing line. After 
refrigeration and storage, C. jejuni could be isolated 
from 67% of carcasses which were sampled. Smeltzer (1981) 
isolated C. jejuni from 94% of fresh, commercially 
processed chicken carcasses.
Oosterom et al. (1983) demonstrated a high rate of
introduction of C. jejuni into two broiler processing 
plants in the Netherlands. The organism was detected on 
feather plucking machinery and evisceration and packing 
areas, resulting in significant contamination of poultry 
meat. Cross infection of carcasses during processing was 
investigated by Wempe et al. (1983) who demonstrated the 
role of feather pluckers and chilling tanks in 
dissemination of C. jejuni. The organism was isolated 
from 60-100% of cecal samples of broilers in which levels 
of 106 CFU/gram of ingesta were attained.
Luechtefeld and Wang (1981) examined fecal, rectal and 
cecal swabs from 600 turkeys delivered to a USDA-approved 
processing plant. Campylobacter jejuni was recovered from 
100% of fecal samples which were examined. The organism 
was also isolated from conveyors in the packing area, 
waste gutters and water treatment lagoons. Christopher, 
Smith and Vanderzant (1982) reported the presence of 
C. jejuni in 85% of chicken livers and 89% of gizzards 
sampled immediately after evisceration.
Yusufu et al. (1983) conducted a prevalence study in 
two California turkey processing plants. They reported
isolation rates of up to 23% from feathers, 6% in scald 
water overflow, 95% in drip water from feather pickers, 
78% in recycled water used to clean gutters, 93% from ceca 
and 61% from water used to wash carcasses. Defeathering 
equipment contributed significantly to cross
infection.
Marjai et al. (1982) reported isolation of C. jejuni
at every phase of chicken processing in a study conducted 
in Hungary. A prevalence rate of 84% was obtained from
intestinal samples. Of 118 specimens derived from
carcasses ready for delivery to consumers, 88 (75%) were
found to be contaminated.
Campylobacter jejuni has been recovered from poultry 
meat at retail outlets, suggesting that the organism can 
be transmitted from poultry to man as a food-borne 
infection. Park, Stankiewicz and Lovett (1981) examined 
whole chicken carcasses from 20 different food stores in 
Ohio and Ontario, over a 5-week period. The authors
recovered C. jejuni from 54% and 62% of the carcasses 
respectively. Kinde, Genigeorgis and Pappaioanou (1983) 
noted an 83% recovery rate in packaged chicken wings in 
California. The isolation rate declined to 16% after cold 
storage for 6 days. Rayes, Genigeorgis and Farver (1983) 
recovered C. jejuni from 50% to 60% of fresh and frozen 
turkey wings. Giblets were shown to be the most 
frequently contaminated turkey portions, with isolation 
rates attaining 42% (Dromigny et al. 1985).
The extent of C. jejuni infection in live chicken, 
ducks and turkeys and their products suggest that these 
species represent a significant zoonotic potential for 
consumers.
Shanker et al. (1982) demonstrated that 75% of a
sample of broiler flocks in Australia were infected with
C. jejuni and that the organism was present in 45% of
carcasses which were examined. A concurrent study
indicated that 98% of 46 C. jejuni isolates derived from 
humans with enterocolitis and 82% of 19 isolates from 
broilers correspond to biotype I. This suggested an 
epidemi- ological relationship between the consumption of 
broiler meat and enteric diseases in humans.
Contaminated chicken meat has been demonstrated to be 
the cause of C. jejuni infection in man. Hayek and 
Cruickshank (1977) reported that prepared chicken was 
associated with gastroenteritis in 5 out of 25 guests at a 
reception. All patients demonstrated an elevated agglu­
tinating antibody titre to C. jejuni and the organism was 
recovered from one individual. In the Netherlands, 89 out 
of a group of 123 cadets developed diarrhea after 
consumption of undercooked chicken (Brouwer et al. 1979). 
Campylobacter jejuni was recovered from 33% of 85 fecal 
samples which were examined. Consumption of poultry meat 
was the cause of two out of five food-borne disease 
outbreaks investigated by the Center for Disease Control 
in the U.S. in 1980 (CDC 1983) and C. jejuni was
implicated in both outbreaks involving 170 cases.
In Sweden an outbreak of campylobacter enteritis among 
the staff of a poultry abattoir was reported by 
Christenson et al. (1983). During a holiday season
inexperienced teenage workers replaced some of the regular 
staff. Within a week, 40% of the employees developed 
gastroenteritis but 71% of the substitutes were affected 
compared to only 29% of the regular workers. 
Campylobacter jejuni was isolated from the feces of 76% of 
substitutes and 55% of the regular employees. 
Contaminated poultry carcasses are a potential source of 
C. jejuni infection for abattoir workers and campylobacte­
riosis may be regarded as an occupational disease, 
especially if improper handling and deficiencies in
personal hygiene exist.
Oosterom et al. (1984) conducted a retrospective study 
of household contacts of patients yielding C. jejuni. An 
isolation rate of 8.5% was obtained compared to 5.1% for 
Salmonella spp. and 1.4% for Shigella spp. The authors
implicated chicken meat as a source of infection 
particularly when barbeque cooking was used. There was no 
significant association between infection and consumption 
of pork, beef or mutton. Similar findings were reported
by Deming et al. (1987) in Georgia who employed a case
control technique to identify risk factors for C. jejuni 
infection. When age, sex and residence were matched the 
odds ratio for eating undercooked or raw chicken was 
calculated to be 49%, compared to only 7% for eating fully
cooked chicken. This study confirmed that raw, 
undercooked or barbequed chicken is a highly significant 
risk factor for C. jejuni infection.
Rosenfield et al. (1985) reported the first outbreak in 
Australia in which C. jejuni was isolated from both human 
patient and their food. The isolates were demonstrated to 
be serologically identical. A chicken casserole was 
identified as the source of infection for 7 out of 17 
affected guests. A food specific attack rate of 58% was 
calculated for the implicated chicken meal. Penner 
serotype 18(21,29) was isolated from 3 of 4 symptomatic 
patients and also from 3 samples of raw chicken, represen­
tative of the batch used to prepare the meal.
4:3. Other meat products
Consumption of undercooked hamburger was suggested as 
the source of infection for an outbreak of Campylobacter 
enteritis in the Netherlands (Oosterom et al. 1984) while 
undercooked pork was regarded as the vehicle in a Japanese 
study (Yanagisawa 1980). Raw clams were shown to be the 
cause of an outbreak of campylobacteriosis in New Jersey
where 18 out of 31 subjects at risk were clinically 
affected (Blaser, 1982). Turnbull and Rose (1982) 
reported isolation of C. jejuni from minced beef in a 
retail outlet demonstrating that red meat could serve as a 
possible source of infection.
Strum (1986) documented a case involving a 50 year old 
woman who developed campylobacteriosis following 
consumption of raw oysters. Fecal samples, which were 
subjected to examination following a 9 month history of 
intermittant diarrhea, yielded heavy growth of C. jejuni. 
Diarrhea ceased following administration of erythromycin.
4:4. Milk
Unpasteurized milk is a frequent source of C. jejuni 
infection in humans. Taylor, Weinstein and Bryner (1979) 
reported 3 confirmed cases of campylobacteriosis, 
following consumption of certified raw milk in Los 
Angeles. Blaser et al. (1979) reported on an outbreak of 
gastroenteritis in which 3 members of a family became ill 
after consuming milk from a cow which subsequently yielded 
C. jejuni. Porter and Reid (1980) recorded a case of 
Campylobacter enteritis with an attack rate of 50%
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following consumption of unpasteurized milk. The organism 
was isolated from both sympt CIuCi t l C  and asymptomatic 
consumers and from milking equipment.
Jones et al. (1981) documented an extensive outbreak in 
which 2500 children were infected after consuming milk 
contaminated with C. jejuni. Thirteen outbreaks of campy­
lobacteriosis associated with raw milk were reported in 
England and Wales between 1978 and 1981 (Robinson and 
Jones, 1981). Potter et al. (1983) documented an outbreak 
in Georgia involving 50 patients in 30 households who 
developed gastroenteritis attributed to C. jejuni. Milk 
from a certified dairy was the common source of infection 
and fecal samples from cows in the herd yielded C. jejuni. 
Commercial cake icing was responsible for an outbreak of 
campylobacteriosis in Connecticut (Blaser et al., 1982).
Considering the fact 
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recorded, the possibility 
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Roman (1982) reported a 58% 
milking herd in the USA. 
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important 
Doyle and 
of a 
in a 
cows
campylobacteriosis 
of cattle being an 
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carrier state in feces 
Oosterom et al. (1982) 
demonstrated that 5.5% of 200 
the intestinal tract.
4:5. Water
Outbreaks of Campylobacter enteritis have been 
associated with contaminated water. Campylobacter jejuni 
has been isolated from estuarine, river and surface water 
(Knill et al. 1978) suggesting the possibility of 
transmission of the pathogen to humans and animals. A 
presumptive water-borne outbreak of C.jejuni enteritis in 
Sweden involving about 2000 cases was reported by Mentzing
(1981). Circumstantial evidence pointed to a common 
untreated water supply as the source of infection. 
Campylobacter jejuni was recovered from 85% of patients 
although contamination of drinking water was not confirmed 
by isolation of the organism. Effluent from a flock of 
20,000 laying hens, upstream from the area from where the 
subject population obtained its water supply was assumed 
to be the source of contamination.
Vogt et al. (1982) repor 
Vermont, involving 3000 pati 
Unfiltered and untreated wate 
system was responsible for
(1983) identified the same
ted a diarrheal illness in 
ents during a 2-week period, 
r supplied by the common town 
infection. Palmer et al. 
biotype of C. jejuni from
infected patients and their water supply, confirming the 
relationship between contaminated water and an outbreak of 
campylobacteriosis.
Sacks et al. (1986) documented a 56% gastroenteritis 
attack rate in residents consuming city water in 
Greenville, Florida. This value compared to an attack 
rate of only 9% among residents of homes not supplied by 
city water. The common water source was from a deep well 
system with an open top treatment tower. Birds were 
costantly seen perched on the tower presumably 
contaminating the water. Campylobacter j e juni was
isolated from 11 of 72 patients with diarrhea and in 
addition from 37% of 38 birds trapped in the vicinity of 
the well. It is necessary however to identify the 
respective serotypes of C. jejuni isolates derived from 
human cases and birds before concluding that free living 
avian species are responsible for contamination of water 
supplies.
Taylor et al. (1983) reported outbreaks of C. jejuni 
enteritis associated with consumption from mountain 
streams in the Grand Teton National Park, Wyoming. The 
report indicated that C. jejuni was isolated from 24% (21 
of 87) and 23% (41 of 178) of patients with diarrhea 
during the summers of 1980 and 1981 respectively.
Approximately 60% of patients with confirmed C. jejuni 
infection had consumed water from mountain streams during 
a 2 week period prior to the onset of illness. 
Campylobacter jejuni was isolated from 2% of the 586 water 
samples.
Chapter 5
OTHER MODES OF TRANSMISSION 
5:1. Direct transmission
Epidemiological studies suggest the possibility of 
direct transmission of C. jejuni. Pai et al. (1979) 
documented the isolation of C. jejuni from 43% of 1004 
diarrheic children in a Canadian hospital. Spread of C. 
jejuni infection among 72 household contacts was 
documented in 6 of 24 families studied. Five children and 
4 adult contacts of 18 patients excreted C. jejuni in 
feces while 5 children and 3 adults showed gastro­
intestinal involvement. A common source of infection was 
responsible for symptoms in 3 of 4 members of one family 
who excreted C. jejuni within a 3 day period. Direct 
transmission was suggested in a family in which 3 members 
out of 5 became infected after intervals of 2-4 weeks.
Blaser et al. (1981) presented evidence of direct 
transmission of C. jejuni in two families. The first case 
involved a 2 year old male child who developed bloody
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diarrhea and fever. Fecal cultures yielded C. jejuni and 
the patient recovered following erythromycin therapy. 
Within a period of 20 days 3 members of the family 
developed similar symptoms. Fecal cultures of 2 of the 
contacts yielded C. jejuni and all 3 recovered following 
administration of antibiotics. In a second case, a 30 
year old man with a 9 day history of copious diarrhea 
accompanied by fever, infected two family contacts 
who developed similar symptoms within 3 days and a third 9
days after the initial onset of illnesses. Facal samples
from all patients yielded C. jejuni. It was concluded
from the course of illness that direct transmission of 
C. jejuni occured.
Neither vaginal nor coital transmission of C. jejuni 
have been demonstrated in humans (Blaser et al., 1979), 
infection has been reported among homosexual men. Quinn 
et al. (1980) documented 5 cases of proctitis from which
jejuni was isolated. In a typical case, a 22 year old 
male presented with a 9 day history of watery, and 
sometimes bloody diarrhea and anal pain. He denied 
contact with pets or farm animals, had not been exposed to 
with persons who had a similar illness and had not
consumed under-cooked or raw food. He acknowledged sexual 
relationship with several men up to onset of illness.
Rectal cultures which were negative for all common
pathogens yielded C. jejuni. Symptoms resolved sponta­
neously over a two weeks period.
Quinn et al. (1984) recovered C. jejuni from 10 of 158 
homosexual men with gastrointestinal symptoms and 2 of 75 
asymptomatic homosexual men. In contrast, none of the
rectal cultures from a control group of 150 heterosexual 
men and women yielded C. j ejuni. In addition
campylobacter-like organisms were isolated from 26 
symptomatic and 5 asymptomatic homosexual men from the
same study. There was positive correlation between 
Si- jejuni infection and anilinction in the affected
individuals.
In contrast to the findings of Quinn et al. (1984), 
McMillan et al. (1984) documented the results of a 
serological study to indicate that C. jejuni infection in 
homosexual men is not significantly higher than in a 
cohort group of heterosexual men. Serum antibody titers 
of >40 were detected in 10.2% of 187 homosexuals and 8.9 % 
of 169 heterosexuals.
5.2. Perinatal transmission
Maternal systemic bacteremia can lead to fetal
C. jejuni infection (Blaser et al., 1983b). Thomas et al.
(1980) document a case involving a 12 day old male infant 
who developed C. jejuni meningitis. It was disclosed that
the mother had experienced transitory diarrhea during the 
7th month of pregnancy. High maternal IgG antibody was 
demonstrated against the strain of C. jejuni isolated from 
the infant. Gribble et al. (1981) reported a case of 
fetal death attributed to C. jejuni bacteremia. The 
mother who presented during the 18th week of gestation, 
reported chronic diarrhea of 3 weeks duration.
Campylobacter jejuni was isolated from maternal blood,
placenta and fetal spleen.
Vesikari et al. (1981) reported a case in which a 
mother became ill two days after delivery. The baby 
developed diarrhea the following day and stools yielded 
C. jejuni on culture. Both mother and child developed 
antibodies to the same strain of C. jejuni, suggesting 
that transmission occured following fecal contamination of 
the birth canal.
In a neonatal nursery in Canada, 4 patients developed 
C. jejuni enteritis within 5 days. Investigations 
suggested that neither cross-contamination nor a common 
source of infection was likely (Karmali et al., 1984). 
Since the serotypes of C. jejuni isolated from feces of 3 
of the mothers were identical to those isolated from their 
infants, it was concluded that neonatal transmission of 
infection had occured.
Youngs et al. (1985), documented 3 cases of neonatal 
enteritis caused by C. jejuni. All 3 infants showed
mucoid or bloody diarrhea within 72 hours after birth.
The mothers had presented with diarrhea either at delivery 
or during the following day. In all 3 cases, C. jejuni
was isolated from feces of both mother and infant. The
authors suggested that Campylobacter enteritis should be 
considered in neonates presenting with bloody diarrhea.
DiNicola (1986) reported isolation of C. jejuni from 
feces of a 3-day old male infant whose mother had 
intermittant bloody diarrhea 5 days prior to and 4 days 
after delivery. Three other family contacts had 
intermittant diarrhea during the period 2 weeks prior to 
and 1 week after the infant's birth. Diarrhea ceased 
after administration of erythromycin.
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5:3. Transmission by vectors
Umunnabuike and Irokanulo (1986) documented isolation 
of C. jejuni from adult American and oriental cockroaches. 
The gut contents of 3 specimens and the surface of 1 of 
690 adult cockroaches yielded C. jejuni. Notwithstanding 
the low isolation rate (0.5%), the results suggest the 
possible role of insects in C. jejuni contamination of 
food products.
Rosef and Kapperud (1983) isolated Campylobacter spp. 
from houseflies (Musca domestica) captured in the vicinity 
of poultry farms in Norway. Shane et al. (1985) 
infected houseflies with C. jejuni and placed them in 
isolation units with specific pathogen free chicks. The 
organism was recovered from the feet of 20% and from the 
viscera of 70% of flies. Cloacal samples of subject 
chickens yielded C. jejuni 7 days post infection demon­
strating the potential for dissemination of campylo- 
bacteriosis by flies.
Chapter 6
PATHOGENESIS IN MAN 
6:1. Clinical course
Butzler and Skirrow (1979) reviewed the clinical 
manifestations of intestinal campylobacteriosis in humans. 
Infections with C. jejuni do not always produce overt 
clinical signs, asymptomatic carriers and a transitory 
state of infection are frequently encountered. Geriatric, 
pediatric and immunosuppresed patients are most 
susceptible and deaths are usually associated with these 
risk groups.
Practically all patients with campylobacter infection 
show some form of diarrhea. In 90% of patients the attack 
is of sudden onset and usually less than a week in 
duration. (Blaser et al., 1979; Pai et al., 1979; Ponka 
et al., 1984). Feces may be bile stained, mucoid, bloody 
or melenic and be accompanied by flatulence. Five to ten 
evacuations per day during the peak of illness occurs in 
50% to 60% of patients. The presence of abdominal pain is 
noted in the majority of patients, varying from 60% (Pai 
et al., 1979) to 96% (Blaser et al., 1979).
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Fever is present in 75% to 90% of cases. Malaise, 
headache, nausia, emesis and anorexia are some of the 
symptoms associated with campylobacteriosis.
6:2. Extra-intestinal complications
Although C. jejuni is a common foodborne intestinal 
infection in humans, involvement of other organ systems 
has been reported. Thomas et al. (1980) documented a 
case of meningitis in a 12-day old male infant with a 20 
hour history of lethargy and anorexia. It is considered 
significant that both the infant's mother and sister had 
diarrhea of three days duration about 6 weeks before 
delivery. Cerebrospinal fluid yielded an aflagellate 
strain of C. jejuni.
Urinary tract infections have been reported by several 
authors including Davies and Penfold (1979) who documented 
recovery of C. jejuni from the urine in a 77 year old 
patient with dysuria. The patient did not complain of 
diarrhea and symptoms were limited to frequent micturition 
including hourly nocturia. Midstream urine yielded pure 
cultures of C. jejuni. Serum obtained 12 days after the 
onset of illness showed an agglutinating titer of 1:160 to
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the specific infective strain. A similar case described 
by Feder et al. (1986) involved isolation of C. jejuni
from the urine of a 6 year old girl who presented with 
cloudy urine. Neither diarrhea nor fever were present and 
urine yielded C. jejuni on isolation. It would thus be 
justifiable to screen for C. jejuni in cases of chronic 
urinary tract infection in pediatric and geriatric 
patients.
It has been suggested that hemolytic uremic syndrome 
(HUS) may be produced by C. jejuni endotoxins. A case 
described by Delans et al. (1984) involved a 54 year old 
male admitted with acute renal failure accompanied by 
abdominal pain, diarrhea and emesis. Campylobacter jejuni 
was isolated from feces but urine and blood cultures were 
negative. Fumarola et al. (1985) suggested that 
lipopolysachcharide endotoxin of C. jejuni was one of the 
causes of HUS. Fatal HUS in a 4 month old male with 
concurrent enteritis was reported by Hag et al. (1985).
In this case C. jejuni was isolated from the feces and the 
antibody titer against the autogenous C. jejuni strain was 
elevated. Other frequently encountered pathogens such as 
Salmonella spp., Shigella spp., Vibrio spp., enterotoxic 
or enteropathogenic E. coli were absent.
Guillain-Barre' Syndrome (GBS) has been associated 
with C . jejuni infection by several workers including 
DeBont et al. (1986). These authors documented a case
involving a 30 month female infant who developed GBS 9 
days after onset of bloody diarrhea which yield C. jejuni. 
Although diarrhea resolved spontaneously, limb paresis and 
facial paralysis supervened. Administration of 
erythromycin was initiated during the second month of 
illness in response to intermittant diarrhea associated 
with C . jejuni cultures. Recovery followed initiation of 
antibiotic therapy.
Septicemia is a frequent complication of C. jejuni 
infection. Pepersack et al. (1979) described a case 
involving possible transmission of C. jejuni following 
blood transfusion in a 67 year old patient. Septicemia 
was confirmed by C. jejuni positive blood cultures. When 
subsequently tested, the blood donor demonstrated 
antibodies against the same serotype of C. jejuni
suggesting hematogenous transmission.
Fetal loss in a 23 year old woman was reported by 
Gilbert et al. (1981) in which C. jejuni septicemia was 
regarded as the etiology. The patient was admitted during 
the 14th week of gestation showing malaise and fever with 
blood cultures positive for C. jejuni.
Dhawan et al. (1986) documented septicemia in a study 
which included 33 patients with C. jejuni enteritis. As 
36% of patients were under 12 months of age and 24% older 
than 50 years, it was concluded that extra-intestinal 
infection is a specific problem in pediatric and geriatric 
patients.
Persistent C. jejuni infection in an immunocompromised 
patient was described by Johnson et al. (1984). A 26
year old woman demonstrated recurrent bacteremia and 
enteritis caused by a single serotype of C. jejuni over a 
period of twelve months. The isolate was sensitive to the 
bactericidal activity of serum derived from a clinically 
unaffected subject, but not to the patient's serum 
suggesting an immune deficiency. Neither IgA nor IgM were 
detected in the patient's serum and IgG titer was elevated 
only after 7 months compared to a normal response within 
15 days. In this case relapse rather than reinfection 
occured due to suboptimal and delayed antibody response.
Blaser et al. (1986), suggested that serum sensitivity
indicates whether a strain of C. jejuni will cause 
diarrheal illness or extraintestinal symptoms. Intestinal 
strains are usually sensitive to serum in contrast to 
extraintestinal strains. Immunocompromised patients are 
at risk of generalized infection with C. jejuni, which can
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be regarded as a potential systemic pathogen resulting in 
conditions other than enteritis (Table 5).
Table 5: Extraintestinal C.jejuni infections
Guillain-Barre' 
Syndrome
Bacteremia
Arthritis
Peritonitis
Polyneuritis
Myocarditis
Meningitis
Abortion
Circadian Urticaria 
Chestwall abscess
Constant et al. 
Pryor et al. 
Davidson & Abbott 
Franciola et al. 
Kowalec et al. 
Bekassy et al. 
Ebright & Ryan 
Kristinsson et al. 
Wroe & Blumhardt 
Florkowski et al. 
Goosens et al.
Iida et al.
Simor et al.
Bretag et al. 
Muytjens &
Hoogenhout
1983 England
1984 Australia
1987 Australia
1985 Swi tzerland
1980 US
1980 Sweden
1984 US
1986 England
1985 England
1984 New.Zealand
1986 France
1986 Japan
1986 Canada
1984 Australia
1982 Netherlands
Chapter 7
ANTIGENIC COMPONENTS
Smith (1977) demonstrated the importance of bacterial 
surface structure in overcoming host defences and 
pathogenicity. The cell surface is the major antigenic 
component of bacteria, since it comes into direct contact 
with host cells. Campylobacter jejuni shows diverse 
antigenic characteristics with more than 60 serotypes 
classified on the basis of heat stable 1ipopolysachcharide 
antigens (Penner and Hennessy, 1980) and 50 serotypes 
differentiated by heat-labile flagellar antigens (Lior 
et al., 1982).
7:1. Surface proteins
Logan and Trust (1983) identified a surface protein 
obtained by glycine buffer extraction. This protein of 
molecular weight 31 Kd, was common to many strains of 
£• 7e3uni• A second outer-membrane protein of 45 Kd has 
been identified in numerous strains.
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7:2. Heat-stable antigen (Lipopolysachcharides)
The lipopolysachcharides (LPS) of C. jejuni consist 
mainly of low molecular weight lipoligosachcharides (Naess 
and Hofstad, 1984). These are similar to the LPS 
described in Neisseria spp. but differ in the fact that 
the molecular weight LPS of C. jejuni are antigenically 
diverse (Walker et al., 1986).
Eldrige, Fox and Jones (1983) subjected the outer 
membrane proteins of C. jejuni to sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis. Hemagglutinating 
activity was present in bands in the 16 to 25 Kd range. 
Lipopolysachcharides extracted using 45% aqueous phenol 
solution yielded a single band in the 10 to 25 Kd range. 
Type-specific hemagglutination activity was detected in 
the elute. The authors concluded that the 10 to 25 Kd LPS 
heat-stable antigen, form the basis of the Penner 
serotyping system. This was supported by the work of 
Burans, Stewart and Bouigeois (1983) who demonstrated the 
heat-stable antigen to be of molecular weight 14 to 21 Kd 
and consisting of short chains without significant O-side 
chain branching.
7:3. Heat-labile antigen (Flagellar Protein)
The flagellum of C. jejuni, which serves as an organ of 
motility, is an important antigenic component (Logan and 
Trust, 1983). Flagellar protein have a molecular weight 
ranging from 57 to 66 Kd and are collectively referred to 
as the 62 Kd protein. The flagellum is important in mucus 
colonization and hence pathogenicity and antigenicity. 
(Newell et al., 1985). This is supported by the presence 
of antibody to C. jejuni flagellin in convalescent human 
serum (Newell et al., 1984).
Wenman et al. (1985) compared the antigenic profiles 
of three strains of C . jejuni with aflagellate mutants 
obtained by ultra violet mutagenesis. Although the three 
strains of origin were serotyped as Lior 5,6 and 7 
respectively, none of the mutants were typable applying 
the Lior system. Thus the flagellar protein was 
identified as an essential determinant of the typing 
system based on heat-labile antigen. The authors 
confirmed the 62 Kd protein to be the flagellar antigen 
specific to Campylobacters. Sera of convalescent patients 
yielded several campylobacter proteins in contrast to sera 
from unaffected controls. The most consistent immunogen
demonstrated in infected patients was the 62 Kd protein, 
which has potential as a vaccine against Campylobacter 
spp.
The antibody produced against flagellae of one serotype 
cross reacts with flagellar antigens of other serotypes. 
This necessitates adsorption of heterologous proteins when 
applying the Lior serotyping technique (Lior et al.,1982).
Chapter 8
MECHANISM OF PATHOGENESIS
After ingestion, an organism enters the potentially 
hostile environment of the intestinal lumen. In order to 
survive, C. jejuni must overcome host defence mechanisms 
and locate a suitable site for adhesion and 
multiplication.
Many factors influence the virulence of C. jejuni and 
other enteropathogens. Attachment to the mucosal surface, 
colonization of the mucosa and invasion, are three 
sequential stages required for infection.
8:1. Mucosal adherence and colonization
A series of experiments conducted by Newell et al. 
(1985a) demonstrated the role of the flagellum after 
jejuni enters the intestinal lumen. Colonization of 
intestine of 4 to 5 day old mice by a clinical isolate of 
C. jejuni and its aflagellate variant were compared. The
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isolate colonized the gastrointestinal tract successfully, 
as demonstrated by an increase in number of organisms 
recovered compared to the infective inoculum. Higher 
numbers of organisms were obtained from the lower small 
intestine, cecum and colon compared to the stomach and
duodenum. Feces yielded C. jejuni for up to 31 days
post-infection.
In contrast, the aflagellate C. jejuni variant did not 
colonize the intestinal tract to the same extent. The 
number of organisms recovered was not significantly 
greater than the inoculum. Feces was negative for 
C. jejuni after 7 days of infection. The authors
concluded that the flagellum plays an important role in 
attachment and colonization and contributes to the 
virulence of C. jejuni.
Isolation of C. jejuni from both healthy and 
experimental animals is an indication of successful 
colonization and attachment of the organism in the
gastrointestinal tract of the host (Butzler and Skirrow, 
1979; Manninen et al., 1982). Dijs and de Graaf (1982) 
demonstrated the absence of adhesive structures such as 
pilli on the surface of C. jejuni by staining organisms 
with phosphotungstic acid and platinum prior to 
examination using an electron microscope.
Elaboration of an adhesin by C. jejuni has been 
demonstrated (Lastovica, 1983; Naess et al., 1983). The 
property of adherence has been shown by Taylor, Ackerman 
and Fox (1985), to be correlated with pathogenicity. 
Fifteen isolates from clinical cases of enteritis and 21 
isolates from asymtomatic carriers were radiolabelled with 
[3H]alanine and [3H]leucine and cultured in chick embryo 
and HeLa cells. Isolates from patients with enterocolitis 
had a greater tendency to adhere to host cells compared to 
C. jejuni organisms derived from unaffected carriers. 
Virulence is dependant on successful colonization of mucus 
and attachment to intestinal mucosa, a property which is 
facilitated by functional flagellae (Gianella, 1981).
8:2. Mucosal invasion
Levine et al. (1983) catogorized enteric pathogens 
into five groups depending on invasive properties.
1. Mucosal adherence and production of an enterotoxin
2. Mucosal adherence and dissolution of the enterocytic 
brush border
3. Mucosal invasion and intra-epithelial cell 
proli feration
4. Mucosal translocation followed by bacterial 
proliferation in the lamina propia and mesenteric 
lymph nodes
5. Mucosal translocation followed by systemic 
infection.
Campylobacter jejuni is responsible for clinical 
changes attributed to three of these mechanisms.
a. Mucosal adherence and enterotoxin production causes 
acute watery diarrhea.
b. Mucosal invasion and epithelial cell proliferation 
results in bloody diarrhea with the presence of 
inflammatory cells in feces. Cellular damage and necrosis 
occurs in the terminal ileum and the colon (Walker et 
al., 1986). Blaser et al. (1980b) demonstrated inflamatory 
infiltrates in the lamina propia and crypt abscesses, 
similar to the lesions produced by Salmonella spp.and 
Shigella spp. These changes may be detected in the 
tissues obtained by rectal biopsy as documented by Price 
et al.,(1979) and Duffy et al.,(1980).
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c. Campylobacter jejuni has the ability to translocate 
to the mesenteric lymph nodes in gnotobiotic mice (Youssef 
et al.,1985).
Mucosal translocation and 
bacteria in the lamina propi 
ranging from severe dysente 
(1977) described a case 
involvement in a 33 year old 
diarrhea. An emergency lapa 
acute abdominal pain ascribed 
On examination, the ileum 
inflamed and edematous. Seve 
lymph nodes were present and 
feces.
subsequent proliferation of 
a results in clinical changes 
ry to hematochezia. Skirrow 
of mesenteric lymph node 
female patient with profuse 
rotomy was performed due to 
to perforation of the bowel, 
was found to be severely 
ral large 'fleshy' mesenteric 
C. jejuni was isolated from
Phagocytosis may influence the virulence of C. jejuni. 
Kiehlbauch et al. (1985) showed that, the organism may 
survive within the cell for up to 7 days and subsequently 
exert a pathogenic effect similar to Salmonella typhi.
Invasiveness of C. jejuni in- vitro was demonstrated 
by Moyen et al., 1985) using a HeLa culture system. Cells 
were incubated with 10 organisms for 1 hour at 37°C in an 
atmosphere containing 5% carbon dioxide. Invasive strains 
of C. jejuni were located within 10% or more cells with at
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least 20 bacteria per cell. Of the 40 strains derived 
from humans, 23 (58%) were non-invasive, 11 (28%) were
invasive and 6 (14%) were intermediate.
Isolates of C. jejuni may exhibit one or more 
characteristics such as adherence, invasiveness, 
intracellular proliferation and translocation. Virulence 
and clinical response will depend on the specific 
characteristics of the isolate and the extent to which 
these properties are expressed.
Chapter 9
SEROTYPING
In 1957 King documented the isolation of pathogens 
referred to as 'related vibriosThese organisms obtained 
from four cases of human enterocolitis demonstrated some 
morphological characteristics in common with Vibrio fetus. 
Since this time progress has been made in the taxonomy and 
definition of biochemical criteria of the group, later to 
be assigned to the new genus Campylobacter. The first 
attempt to classify Vibrio fetus, using serological 
techniques, was reported by Berg et al. (1971). These 
authors extracted heat labile and heat stable antigens 
from Vibrio strains derived from 6 outbreaks of 
enterocolitis. Antigens were inoculated into rabbits to 
produce reference antisera which were then used to develop 
a serotyping scheme. Though both heat-labile (H) and 
heat-stable (0) antigens were evaluated, only heat stable 
antigen was used in a combined sero-biotyping scheme, 
since the 'H' antigen reacted to more than one antiserum. 
Three distinct serotypes and two biotypes were recognized, 
forming the basis of an identification system. The five 
catogories of Vibrios which were identified by the 
sero-biotyping system comprised:-
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Group 1: Serotype A-Biotype I (A-I),
Glycine negative, hydrogen sulfide negative.
Group 2: Serotype A-Bio subtype I (A-sub I),
Glycine negative, hydrogen sulfide positive
Group 3: Serotype A-Biotype II (A-II),
Glycine positive, hydrogen sulfide positive
Group 4: Serotype B (B).
Group 5: Serotype C (C).
Berg et al. (1971) related these serogroups to bio­
chemical characteristics and the clinical manifestations 
in various species. Group A-I and A-sub I were 
responsible for vibrionic infertility in cattle and were 
not able to survive in the intestinal tract. Group A-II, 
B and C were associated with abortion in sheep but could 
tolerate an intestinal environment.
Comparison between the type species Vibrio cholera
isolated by Pacini in 1854 and the 'related vibrios' 
described by King in 1957 confirmed the biochemical
differences between the groups, notwithstanding
morphological similarities. Campylobacter was advanced
as a new genus by Sebald and Veron (1963). The principal 
differences between Campylobacter spp. and Vibrio spp. as 
defined by Veron (1982) are summarized in Table 6.
Following the investigation of Veron and Chatlain
(1973), it was accepted that group C vibrios described by 
Berg et al. (1971) were C. jejuni.
Butzler and Skirrow (1979) serctyped Campylobacter 
isolates using both heat labile and heat stable antigens. 
Six serotypes were identified among 90 isolates. In 
addition Campylobacters could be differentiated into two 
biotypes on the basis of hydrogen sulfide production. 
Abbott (1980) used the 'O' and 'H' antigens to serotype 
six strains of C. jejuni using a tube agglutination 
method. Lauwers (1981) employed a plate agglutination 
technique to identify 16 serogroups among 300 isolates.
A major advance was represented by the studies 
conducted by Penner and Hennessy (1981) and Lior et al in
(1982) who independently developed serotyping schemes. 
These identified specific antigens and facilitated the 
recognition of a greater number of serotypes of C. jejuni. 
Penner and Hennessey (1981) employed a passive 
hemagglutination procedure in which a saline extract was
Table 6. Differences between the genera Vibrio and 
Campylobacter
Characteristic Vibrio spp. Campylobacter spp.
(Pacini, 1854) (Sebald and Veron, 1963)
Morphology curved or straight curved or helicoidal
Coccoid forms occasional frequent
Respiration aerobic microaerophilic
Glucose fermentative not metabolized
metabolism (without gas)
Source: Veron, 1973.
prepared from the soluble, heat stable 'O' antigen 
comprising the surface lipopolysachcharides (LPS). 
Antisera to these antigens produced in New Zealand white 
rabbits were used to identify 23 serotypes from among 91 
isolates of C. jejuni. About 60 serotypes have now been 
identified by the Penner method (Penner et al., 1983).
Lior et al. (1982) identified 21 serotypes from a 
collection of 815 isolates using heat labile 'H' antigens. 
These flagellar antigens derived from formalinized, 
inactivated suspensions of C. jejuni were used by Lior et 
al. (1982) to prepare a range of antisera in New Zealand 
white rabbits. The polyclonal antisera were adsorbed with 
homologous heat stable and heterologous, cross reactive 
antigen suspensions. The Lior serotyping system, which is 
read using slide agglutination, can be used to identify 
over 50 serotypes.
A comparison between the Penner and Lior systems 
conducted by Patton et al. (1985) indicated that the 
Penner system is marginally superior in specificity. A 
total of 96.1% of 1405 isolates could be typed using the 
Penner system in comparison to 92.1% with the Lior method. 
A disadvantage of the Penner system is that a small 
fraction of antigens may react with multiple antisera. 
The method does not require adsorption of heterologous 
antisera.
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Of the human and non-human isolates, which have been 
routinely typed using the Penner system, approximately 50% 
react to only one antiserum. Approximately 30% react with 
two antisera while the remainder (20%) react with three or 
more antisera. In the majority of multiple reactions, one 
antiserum predominates with weak reactions associated with 
the second or third antisera. Generally when conducting 
epidemiologic investigations, isolates reacting with more 
than one antiserum are assigned to a type corresponding to 
the strongest reacting antigen. Multiple reactors are 
designated as 16(1), with 16 as the primary antigen and 1 
as the weak secondary reaction. In most instances 
multiple reactions occur in specific combinations such as 
36(23), 8(17), 44(1).
The method of Lior identifies a larger proportion of 
C. jejuni antigens which react to single antisera, but the 
technique has the disadvantage of requiring a multiple 
absorption process. Though the Lior method is simpler and 
involves less expensive equipment, the Penner system is 
considerably faster for diagnostic laboratory appli­
cations .
Chapter 10.
TOXIGENICITY 
10:1. Introduction
Campylobacter jejuni has been isolated from both 
healthy individuals (Rajan and Mathan, 1982) and from 
diarrheic patients (Stoll et al., 1982; Bokkenheuser and 
Sutter, 1981). Companion animals, especially dogs and 
cats may serve as healthy carriers of C. jejuni (Hosie et 
al., 1979), but a higher prevalence is noted in diarrheic 
animals (Ferreira et al., 1979). Campylobacter jejuni has 
been isolated from clinically normal chickens (Simmon and 
Gibbs, 1979), cattle (Bryner et al., 1972), zoo animals 
(Luechtefeld et al., 1981) and laboratory species (Fox, 
1982) .
The isolation of C. jejuni from both healthy and 
clinically affected humans and animals presupposes the 
existence of virulent and non-virulent strains amongst the 
isolates. Determination of the virulence of C. jejuni 
isolates obtained from humans and animals has included
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animal models, iji vivo trials and jji vitro studies 
involving cell-association and penetration (Newell et al.,
1985) .
Reports relating to quantitative assay of specific 
toxins produced by isolates of C. jejuni are limited. 
This contrasts to the research on quantifying the 
enterotoxins of V. cholera and E. coli (Yolken et al., 
1977; Back et al., 1979; Sack et al., 1980; Bongaerts,
1985) .
10:2. Toxins
Both an enterotoxin and a cytotoxin have been 
identified from C. jejuni. The enterotoxin is considered 
an endotoxin while the cytotoxin is an exotoxin. 
Campylobacter jejuni strains may produce either, both or 
neither of these toxins. Production of toxins in-vitro 
depends on provision of suitable media and growth 
conditions.
10:2(1). Enterotoxin
Ruis-Palacios et al. (1983) demonstrated a cholera­
like enterotoxin from 24 out of 32 isolates of C. jejuni 
derived from diarrheic patients using the Chinese Hamster 
Ovary (CHO) cells and the Cyclic Adenosine Mono-Phosphate 
(cAMP) assay. Of 6 strains isolated from carriers, only 1 
produced the toxin. The author further characterized the 
toxin as heat labile at 56°C for 1 hour with a molecular 
weight of 10 to 100 Kd and was inactivated by pH below 2 
and above 8. McCardell et al. (1984a) reported a similar 
finding using ELISA, CHO and adrenal tissue (Yl) cell 
assays.
10:2(2). Cytotoxin
In 1983 Yeen et al. demonstrated a toxin produced by 
C. jejuni which caused destruction of HeLa cell in 24 to 
48 hours. The toxin caused cell rounding, nuclear 
pyknosis, loss of cell adherence in monolayers and death 
and floatation of cells. Since sonicated bacterial cells 
did not show toxin activity, the authors suggested that 
death of host cells was caused by an exotoxin and not an 
endotoxin. The toxin was shown to be heat labile at 100°C 
for 30 minutes. Johnson and Lior (1984) documented 
similar findings using Vero cells. They were able to show 
cytotoxic activity in more than 60% of the 80 isolates 
derived from fecal samples in contrast to cytotonic 
(enterotoxic) activity in more than 85% of the isolates. 
Goosens (1985) used CHO cells to demonstrate cytotoxins 
produced by 33 out of 39 C. jejuni strains isolated from 
patients with watery stools.
McCardell et al. (1986) characterized the cytotoxin
to comprise of two units. Cytotoxin 1 has a molecular 
weight of 70 kd and an isoelectric point of 9.0. This 
unit was heat stable at 100°C for 5 minutes, was trypsin 
resistant (1 mg/ml/hr at 37°C) and caused hemagglutina­
tion but not hemolysis in rabbit erythrocytes. The second
unit, cytotoxin 2, was trypsin sensitive, heat labile and 
hemolyses rabbit erythrocytes.
Enterotoxin produced by C. jejuni has similar character 
istics to the toxins of Vibrio cholerae and E. coli. All 
three toxins are heat-labile, elevate cAMP production, 
elongate CHO cells and neutralize anti-cholera toxin serum 
(McCardel et al., 1984b). Due to the similarity between 
the enterotoxins of C. jejuni and E. coli both in respect 
to antigenicity and physical properties, most assays to 
quantify the enterotoxins of E. coli or V. cholerae may be 
applied to C. jejuni.
10:3. Assays
10:3(1). Enzyme Linked Immunosorbent Assay
Holmgren et al. (1973) reported that a specific glyco-
lipid, ganglioside GMl, contains a receptor structure 
which fixed cholera toxin in a double-diffusion gel 
precipitation technique. Due to the specific fixation of 
enterotoxin, ganglioside GMl was subsequently used to bind 
cholera toxin in a modified enzyme linked immunosorbent 
assay (GM1-ELISA) as shown in Figure 4.
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Svennerholm and Wiklund (1983) describe a GMl-ELISA in 
which microtiter wells were coated with GMl to bind 
E. coli enterotoxin, thus increasing the sensitivity of 
the assay. Bongaerts (1985) effected modifications to the 
GMl-ELISA to expedite the assay to allow completion within 
8 hours.
Enterotoxin of C. jejuni was shown to be immuno- 
logically similar to cholera toxin by McCardell et al.
(1984b) and to E. coli enterotoxin by Klipstein and Engert 
(1985). Thus GMl-ELISA can be used to assay C. jejuni 
enterotoxin.
Ruiz-Palacios (1985) and Klipstein(1986) have success­
fully applied the GMl ELISA modification to assay 
heat-labile enterotoxin of C. jejuni.
The following reactions occur during GMl ELISA:
a. GMl fixes LT (labile toxin of C. jejuni)
b. LT binds CT-IgG (goat serum against cholera toxin)
c. CT-IgG is bound by horseradish peroxidase conju­
gated anti-goat serum (in rabbits)
d. Horseradish peroxidase reacts with O-phenyldiamine 
dihydrochloride substrate to produce a color 
reaction.
If a culture filtrate from a C. jejuni isolate contains 
a labile toxin, the positive color reaction can be 
detected and quantified using a spectrophotometer.
10:3(2). Cell culture assay
Cell culture assays have been used extensively to 
detect enterotoxins of V. cholera and E. coli. Donta et 
al. ( 1974 ) used adrenal cell lines (Yl cells) for
detection of E. coli enterotoxin while Guerrant et al
(1974) employed Chinese hamster ovary cells (CHO) for 
studies on V. cholera and E. coli toxins. Speirs et al. 
(1977) assayed the enterotoxin activity of E. coli using 
Vero cells. Gubina et al. (1980) and Ruiz Palacios,
(1983) quantified the enterotoxins of C. jejuni using CHO 
cell lines.
Two approaches have been used to assay enterotoxins 
using CHO cells.
a. Cyclic Adenosine Monophosphate assay:
Schaffer et al. (1970) reported an elevation in the 
concentration of adenosine 3':5'~ cyclic monophosphate
(cAMP) in the intestinal mucosal cells of rats after 
treatment with cholera toxin. Similar results were 
reported by Bourne et al. (1973) who demonstrated an 
accumulation of cAMP in human leukocytes caused by cholera 
enterotoxin, in contrast to other agents such as 
prostaglandin-El. Guerrant et al. (1974) evaluated the 
effect of enterotoxins in-vitro by incubating CHO cells 
with either cholera toxin or E. coli heat-labile toxin. 
The cAMP concentrations were assayed by the procedure of 
Gilman (1970), who reported a significant increase in cAMP 
levels by both toxins. An elevation in level of cAMP over 
controls indicated the presence of an enterotoxin.
b. Cell Morphology Assay:
Hsie et al. (1971) and Hsie and Puck (1971) noted 
morphological changes in CHO cells, produced by cAMP. 
Affected cells showed bipolar elongation and the number of 
cells showing changes was proportional to the 
concentration of cAMP. The cAMP effect on cells, which is 
opposite to the response stimulated by malignant viruses 
or carcinogenic agents, is called reverse transformation.
Puck et al. (1972) detailed the mechanisms by which
cAMP affected the integrity of membranes in mammalian
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cells. Knob-like structures on the cell membrane are lost 
within 15 minutes and the membrane becomes smooth. Cyclic 
AMP causes organization of the microtubular 
microfibrillar (MT-MF) system resulting in an increase in 
microtubules which become arranged into parallal arrays. 
Following this stage the cell elongates to assume a
fibroblast like morphology. Elongation is visible after
5-8 hours depending on the concentration of cAMP.
Ruiz-Palacois et al. (1983) reported both elongation 
and increased cAMP production in CHO cells when incubated
with 24 - 36 hour cultures of C. jejuni obtained from
patients with diarrhea. A total of 75% of the 32 isolates 
from diarrheic patients showed enterotoxin activity 
denoted by morphological and cAMP assay. Only 1 of 6 
isolates from non-affected carriers showed any detectable 
toxin activity. Elongation of CHO cells, which indicates 
the presence of enterotoxin may be used to characterize 
isolates of C. jejuni.
Chapter 11.
CONCLUSION
Campylobacter jejuni is one of the significant 
pathogens causing enterocolitis in humans. Due to 
microaerophilic and thermophilic requirements and the 
prolonged lag phase of growth, C. jejuni was relatively 
obscure prior to the late 1970's. The development of 
selective media and microaerophilic gas systems, 
facilitate isolation and propogation of C. jejuni which is 
now frequently recovered from man and animals. In order 
to understand the epidemiology of campylobacteriosis and 
the zoonotic implications of C. jejuni, extensive investi­
gations have been initiated during the past five years.
Campylobacter jejuni may be isolated from affected 
human and animal patients, in addition to healthy 
individuals who maintain the organism in the intestinal 
tract. The prevalence of C. jejuni in humans is higher in 
third world nations than in developed countries and the 
organism is more frequently isolated from patients with 
gastrointestinal conditions (Table 7).
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The prevalence of C.jejuni in the human population may 
range from 0 to 31% depending on the age of the population 
surveyed, country, socio-economic conditions and inter­
current disease or parasitism. Isolation of C. jejuni
from non-diarrheic patients is not unusual and frequently 
the organism cannot be recovered from feces of a patient 
with gastrointestinal signs. Detecting an increase in 
circulating antibody titer is a reliable indication of 
infection.
Infection with C. jejuni may be asymptomatic or produce 
a wide range of changes including watery diarrhea, severe 
enteritis with ulceration of the lower intestinal tract, 
hematochezia and generalized malaise (Walker et al.,
1986). Clinical severity depends on the elaboration of 
toxin by the strain infecting the patient. Some serotypes 
of C. jejuni produce an enterotoxin which is chemically 
similar to the toxin of Vibrio cholerae causing profuse 
diarrhea while others elaborate a cytotoxin which induces 
a local inflamatory reaction resulting in bloody or mucoid 
diarrhea. Many strains are known to produce both toxins. 
The severity and nature of campylobacteriosis depend on 
the degree of expression of these two toxins. 
Campylobacter jejuni is also associated with several 
systemic infections such as meningitis, myocarditis, 
arthritis, nephritis and conditions such as hemolytic
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Table 7: Prevalence of C. jejuni in specific populations
Asymptomatic Diarrheic
individuals patients
Third World 1 1
nations | 5-17% | 
1 1
8-31%
Developed 1 1
nationss | 0-1% | 
1 1
4-7%
uremic and Guillain-Barre' syndromes (Walker et al.,
1986).
Avian species, including commercial poultry have been 
identified as an important reservoir of C. jejuni as
denoted by isolation rates of up to 90% in layer and
broiler flocks and 100% in turkeys. Intensive commercial 
management of poultry, has contributed to the maintenance 
of a reservoir state which has significant human health 
implications. Although C. jejuni is reported to cause 
hepatic lesions in mature chickens, infection is currently 
not regarded as a disease entity in the poultry industry.
Re-use of litter and deficiancies in biosecurity are 
important in maintaining the cycle of C. jejuni infection. 
Broilers which are grown on litter are more likely than 
commercial layers to carry C. jejuni infection at the time 
of slaughter.
Cross contamination occurs between infected and clean 
carcasses at various sites in the processing plant such as 
the scalding tank, defeathering machines, evisceration 
line and chill tank (Wempe et al., 1983). Since 70% of
oven-ready carcasses and portions are contaminated,
consumption of under cooked or raw chicken may lead to 
food-borne campylobacteriosis.
Conclusive evidence of food borne campylobacteriosis is 
represented by a correspondence in serotype between 
isolates from a food source and affected patients. 
Approximately 60 C. jejuni serotypes have been identified, 
using either the Penner or the Lior system.
Campylobacter jejuni may elaborate either or both, 
enterotoxins or cytotoxins. Any C. jejuni serotype may 
be catogorized according to the presence (+) or abscence 
(-) of toxin.
Type Cytotoxin Enterotoxin 
1 + +
2 +
3 +
4 -
Infection with a strain which is enterotoxin-positive 
and cytotoxin-negative will most likely result in watery 
diarrhea. A cytotoxin-positive, enterotoxin-negative
strain will cause severe enteritis with hematochezia 
accompanied by abdominal pain. Strains with neither toxin 
result in asymptomatic infection in contrast to serotypes 
which elaborate both toxins which may evoke watery to 
bloody diarrhea with malaise and abdominal pain.
There is no specific study on the epidemiology or 
prevalence of C. jejuni infection in either animal or 
human populations in Louisiana. The present study 
using both serology and toxigenecity assays was initiated 
to obtain an understanding of the epidemiology of 
Campylobacteriosis.
Chapter 12
PROCEDURES
The general objective of the research program concerned an 
investigation of the prevalence, serotype and 
pathogenicity of C. jejuni.
12:1. Prevalence study
The objective was to determine the prevalence of 
C* jejuni in diarrheic patients and in avian cases 
submitted to a diagnostic laboratory.
12:1(1). Sampling techniques
This study of prevalence of C. jejuni in avian species 
comprised the cases submitted to the Louisiana Veterinary 
Medical Diagnostic Laboratory during the period February 
1987 through July 1988. In addition, hunter-killed 
Anseriformes, available in the vicinity of the Rockefeller 
Refuge, Cameron Parish, Louisiana, were sampled. Cloacal
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swabs from all cases were routinely cultured for 
C. jejuni.
Fecal specimens from human patients with diarrhea 
comprised both admitees and outpatients at the Our Lady Of 
The Lake Regional Medical Center, Baton Rouge, Louisiana. 
Submissions during the period August 1987 through July 
1988, were routinely cultured for the presence of 
C. jejuni.
12:1(2). Culture and identification of C. jejuni
Figure 3 is a diagramatic representation of the 
procedures to identify C. jejuni isolates.
a. Culture and isolation
The selective Campylobacter medium which was used for 
all isolation procedures consisted of a basal medium of 
brucella agar (Difco Laboratories, Detroit, Michigan), 
incorporating 5% ruminant blood and Butzler's Antibiotic 
Supplement (Oxoid Limited, Hampshire, England). Each 3ml 
vial of supplement contained 12,500 units bacitracin, 
25 mg cycloheximide, 5,000 units colistin sulphate, 7.5 mg 
cephazolin sodium and 2.5 mg novobiocin.
Growth on selective medium
/ \
Yes No ----> Eliminates enteropathogens other than
I Campylobacter spp.
Growth at 42° C
/ \
Yes N o --------- > Eliminates C. fetus & C. pyloridis
I
Nalidixic acid sensitivity
./ \
Sensitive Resistant--------------> Eliminates C. laridis
I
Hippurate hydrolysis
/ \
Yes N o ------------------------ > Eliminates C. coli
I
C. jejuni------------------------- > Toxin assay
I I / \
H S production Passive Enterotoxin Cytotoxin
/ \ Hemagglutination / \ / \
Yes No | +ve -ve +ve -ve
Biotype Serotypes 1 to 60
I II
Figure 3. Scheme to speciate and serotype Campylobacter 
jejuni isolates
Fecal swabs were placed in Cary-Blair transport medium 
(Difco Laboratories) and processed within 24 hours. Swabs 
impregnated with biological material were used to 
inoculate plates of selective medium. Incubation was 
carried out at 42°C under microaerophilic conditions in a 
sealed bag containing a mixture of 5% oxygen, 10% carbon 
dioxide and 85% nitrogen (Liquid Carbonic, Baton Rouge, 
Louisiana).
Following incubation for 48 hours, the plates were 
examined for evidence of growth. Primary cultures were 
recognized as flat, non-hemolytic gray colonies with 
spreading borders. Plates were incubated for an 
additional 24 hours if no visible growth was present.
b. Gram staining
A sterile platinum wire loop was used to transfer a 
portion of a colony to a drop of sterile water on a glass 
microscope slide. After mixing, the suspension was 
allowed to dry in air and the preparation was stained with 
a modified Gram stain procedure, substituting basic 
fuchsin for safranin as a counterstain. Slides were also 
stained directly with basic fuchsin for rapid 
determination of morphology.
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c. Motility
Cultures of presumptive Campylobacter spp. were 
incubated in brucella broth for 20 hours at 42°C. A 0.1 ml 
aliquot of the culture was tranferred to a microscope
slide using a sterile pipitte and examined under dark 
field illumination. Characteristic rapid darting
movements indicated the presence of Campylobacter spp.
12:1(3). Biochemical characteristics used in identi­
fication and biotyping (Table 8).
a. Nalidixic acid sensitivity
A colony from the primary culture was streaked onto a 
blood agar plate with a 30 microgram nalidixic acid
Sensidisc (BBL Microbiological System, Cockeysville, MD). 
After incubation at 42°C for 24 hours, cultures were 
examined to determine sensitivity.
b. Hydrogen sulfide production
Hydrogen sulfide production was determined according to 
the procedure described by Lior (1984). A semisolid agar 
base medium containing brucella broth, sodium hypo- 
phosphate, potassium hypophosphate, ferrous sufate, sodium
metabisulfite and sodium pyruvate was prepared, dispensed 
into 3-ml aliquots in sterile 13 X 100 mm screw cap tubes 
and stored under refrigeration. Campylobacter jejuni test 
cultures were streaked for contiguous growth on blood agar 
plates. Using 24-hour cultures, a 10 ul disposable 
plastic inoculating loop was repeatedly drawn across the 
surface of the plates to gather a 5 mm spherical mass of 
bacteria. This inoculum was suspended, without mixing, in 
the upper third of the medium. Inoculated tubes were 
incubated in a 37 °C water bath for 2 hours, then examined. 
A blackening of the bacterial mass indicated sulfide 
production. Campylobacter jejuni Lior serotype 6 served 
as a positive control.
c. Hippurate hydrolysis
Colonies from a secondary culture were mixed with 2 ml 
sterile water in a tube. A hippurate disc (1.6 g sodium
hippurate) as used in the Minitek Identification System
(BBL Microbiological System, St.Louis, Missouri) was added 
to the suspension and the mixture was incubated at 37°C 
for 2 hours. An aliquot of 1 ml ninhydrin solution
prepared by rehydrating 3.5 g crystalline ninhydrin (Sigma 
Chemical Co.) in 100 ml of an equal mixture of acetone and 
butanol was added to the incubated solution. After 2
hours at room temperature, a positive reaction was denoted 
by the development of a blue color in the solution.
Table 8. Differences in characteristics of catalase 
positive Campylobacter spp.
Species Optimal 
growth 
temp.
Nalidixic
acid
sensitivity
Hippurate
hydrolysis
Hydrogen 
sulfide 
prodn.
C. fetus 25 °C R - -
C. coli o o O S - -
C. jejuni(Bio I) 42 °C S + -
C. jejuni(BioII ) 42 °C S + +
C. laridis 42 °C R - -
C. pyloridis 37 °C R ? +
R: Resistant 
S: Sensitive
+ indicates production or reaction 
- indicates no production or reaction 
?: Not known
Source: Skirrow and Benjamin, 1979.
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12:2. Serotyping
Isolates of C. jejuni were examined to determine the 
identity and prevalence of serotypes and to investigate 
whether any commonality existed between the two 
populations in respect of serovars.
Penner serotyping was used to characterize isolates of 
C. jejuni. This system is based on passive hemagglutin­
ation of heat stable, soluble antigens which can be used 
to produce specific antibodies in rabbits. The heat 
stable antigen extracted from an isolate of C. jejuni was 
adsorbed onto sheep erythrocytes to be agglutinated 
against rabbit antisera.
12:2(1). Preparation of antigen
The test isolate was inoculated on campylobacter agar 
plates and incubated at 42°C under microaerophillic 
conditions until confluent growth was obtained (48-72 
hours).
Growth from 4 plates was pooled to prepare antigen. A 
1.5 ml aliquot of isotonic phosphate buffered saline 
(IPBS) at pH 7.0 was flushed on to each plate. The 
solution comprised 8g. sodium chloride, 0.2g. potasium 
hydrogen phosphate, 2.9g. sodium hypophosphate, 0.2g
potasium chloride and 600ul concentrated hydrochloric acid 
in 11 water. Colonies were transferred to a tube using a 
bent glass rod.
The tube containing C. jejuni in IPBS was placed in a 
water bath at 100°C for one hour and thereafter was 
allowed to cool and then centrifuged at 10,000 rpm (12,000 
xg). The supernatant was poured into a glass vial and two 
drops of preservative (1% thimerosal, Sigma Chemical Co.) 
was added to the supernatant. The heat-stable antigen was 
stored at 4°C until further use.
12:2(2). Preparation of antisera
Confluent bacterial growth of C. jejuni reference 
strains (Penner typing) were transferred to 3 ml of 0.85% 
sodium chloride solution, washed twice and resuspended in 
saline.
After a pre-immune blood sample was obtained, New 
Zealand white rabbits (3-4 Kgs) (Hazelton Research
Animals, Devon, Pennsylvania) received 5 sequential 
intravenous inoculations of antigen at 3 day intervals. 
Blood was collected by cardiac puncture 10 days after the 
last injection. Blood was allowed to clot and serum was 
separated for storage at -20°C.
12:2(3). Adsorption of antigen
Sheep blood was centrifuged and the erythrocytes were 
washed three times in IPBS. Erythrocytes were resuspended 
in IPBS at the original volume and the hematocrit value 
was used to determine the percentage of cells in the 
suspension. A 1% cell suspension was prepared by 
appropriate dilution with IPBS.
Antigen was diluted to 1:10 by mixing 0.4 ml of the 
preparation with 3.6 ml of IPBS. An equal volume of 1% 
SRBC suspension was mixed with the antigen, the tubes were 
covered and incubated at 37°C for 1 hour and thereafter 
centrifuged at 2000 rpm for 10 minutes. The supernatant 
was discarded, the SRBC preparation was washed and 
resuspended in the original volume of IPBS. This amount 
of antigen-coated SRBC was sufficient for one 96 well 
plate titration.
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12:2(4). Serial dilution of sera
Sera were stored in undiluted form at -20°C. A series 
of tubes containing 1:5 dilution in IPBS was made from the 
original serum for storage at 4°C with 1% thimerosal as 
a preservative. Serum was diluted to 1:20 with IPBS for 
titration.
A 50 ul dispenser was used to transfer IPBS to each 
well of the microtiter plate (Dynatech Laboratories, 
Alexandria, Virginia). An aliquot of 50 ul of 1:20 
antiserum (in IPBS) was added to the first well of each 
row, yielding a 1:40 dilution of antiserum in the first 
well. A microtiter diluter was used to prepare two-fold 
serial dilutions. The antiserum dilutions for each 
antigen ranged from 1:40 to 1:1280.
12:2(5). Agglutination
Using appropriate dispensers, 50 ul of antigen- 
sensitized sheep erythrocyte suspension was placed in each 
well containing diluted antiserum. The plate was covered 
to prevent evaporation of reagents and incubated at 37°C 
for 1 hour. The plate was then removed and placed in a
refrigerator at 4°C. A minimum of 1 hour was allowed
before the plate was examined for evidence of
agglutination. Plates were routinely retained overnight 
to permit development of color to facilitate recognition 
of hemagglutination.
12:3. Toxigenicity testing
The objective of this study was to investigate the 
toxigenicity of C. jejuni isolates of known serotype using 
cell culture and modified ELISA techniques. Profiles of 
the toxins produced by the isolates were assayed to 
identify the toxigenic strains prevalent in collected 
specimens. This data was intended to serve as a baseline 
for further epidemiologic investigations of campylo- 
bacteriosis in Louisiana. Toxigenic assays were conducted 
to determine whether any relationship existed between 
serotypes and the occurence of disease in either humans or 
animals.
12:3(1). Enterotoxin assay
a. Enterotoxin production
Each test strain of C. jejuni was cultured in brucella 
agar containing 10% ovine blood for 48 hours. 
Approximately 15 CFU was inoculated into brucella broth 
supplemented with a 0.25% mixture each of L-asparagine, 
L-serine (Eastman Kodak Co., Rochester, New York) and 
L-glutamic acid (Difco Laboratories). Cultures were 
incubated at 42°C for 24 hours in a humidified atmosphere, 
followed by incubation for 10 minutes with a suspension of 
500 IU polymyxin B sulphate (Pfizer Inc., New York, New
York). Cultures were centrifuged at 20,000 xg for 20
minutes at 4°C. The supernatant was filtered through a 
0.22 um Aerodisc membrane (Gelman Sciences Inc., Ann
Arbor, Michigan) and immediately tested for toxin
production.
b. GM1 ELISA
This assay is based on the property of ganglioside GMl 
to bind to C. jejuni enterotoxin. Binding of toxin is
detected by a modified ELISA system which requires 
reactions with two successive antibodies and an 
enzyme-substrate reaction (Figure 4). Cholera antitoxin 
is used as the first antibody and horseradish peroxidase 
conjugated anti-goat serum as the second antibody. 
Ganglioside Ml ELISA was performed using Bongaerts 
technique (1984) with modification of Clarke (1986).
A u-bottom, 96 well polyvinyl chloride microtiter plate 
(Dynatech Laboratories Inc.) was used for the procedure. 
Wells were coated with GMl ganglioside (Sigma Chemical 
Co.) by adding 150 ul (100 ug/ml in PBS) per well and 
incubating at 22°C for one hour.
The wells were washed three times with PBS-Tween (PBST) 
(Fisher Scientific Co., Fair Lawn, New Jersey) and 200 ul 
of neonatal calf serum (1% in PBST) was placed in each 
well. The plate was incubated at 37°C for 30 minutes.
The wells were washed three times as previously 
described and 150 ul of test-sample enterotoxin (two-fold 
dilutions of culture supernatants from 1:10 to 1:100) was 
added to each well in each row in sequence. The plate was 
incubated at 22°C for 2 hours.
Enzyme-Substrate
reaction
Enzyme
Anti-rabbit IgG
Rabbit anti-LT
Milk protein
C. jejuni LT
Figure 3: Diagrammatic representation of the principle of GM1-ELISA.
After washing, 150 ul of goat anti-CT (Jackson Immuno 
Research Laboratories Inc., West Grove, Pennsylvania) was 
added at a dilution of 1:1000 to each well and the plate 
was incubated at 37°C for 1 hour in a humidified chamber.
After washing, 150 ul of horseradish peroxidase- 
conjugated rabbit anti-goat serum (Jackson Immuno Research 
Laboratories Inc.) was added at a dilution of 1:1000 to 
each well. The plate was incubated at 37°C for one 1 hour 
in a humidified chamber.
The wells were washed and 150 ul of hydrogen peroxide 
-O- phenylenediamine dihydrochloride (H202-0PD)(Eastman 
Kodak Co.) substrate solution was added to each well and 
the plate incubated at 22°C for 1 hour in the dark.
To stop further reaction after the last step and to 
intensify color, 50 ul of sulphuric acid (H2S04, 2.5
mol/1) (J.T.Baker Chemical Co., Phillipsburg, New Jersey) 
was added to each well.
The optical density of the solution in each well was 
determined using a MR 600 microplate reader (Dynatech 
Laboratories Inc.) at 492 nm. An extinction value of 0.1 
indicated the presence of a significant concentration of
c. CHO cell assay
Morphological changes, comprising an elongation 
(bipolarity) of the rounded cells can be induced by 
enterotoxin of C. jejuni, E. coli and V. cholerae. This 
property is used to demonstrate the presence of toxin 
elaborated by test isolates of C. jejuni. Supernatants of 
brucella broth cultures of C. jejuni were incubated with a 
suspension of CHO cells and the percentage of cells which 
showed morphological changes was recorded.
Stock cultures of CHO cells (American Type Culture 
Collection, Rockville, Maryland) were incubated at 37°C, 
in 6% carbon dioxide in Hams F12 medium (Gibco 
Laboratories, Grand Isle, New York) supplemented with 10% 
fetal calf serum. Cultures were passaged at interva Is by 
trypsinization and seeding of additional flasks.
A suspension of CHO cells was removed to estimate 
concentration using a hemocytometer. An appropriate 
dilution to contain about 5000 cells in 0.25 ml F12 medium 
with 1% fetal calf serum, was added to each of the 96 
wells of a flat-bottomed culture plate. The supernatant 
from a C. jejuni culture (two-fold dilution) was added 
immediately to the cell suspension.
Cells were examined at eight hour intervals for 
evidence of bipolarity and elongation. One hundred cells 
were counted and the percentage of elongated cells was 
determined. Elongation in 50% or more cells denoted the 
presence of enterotoxin. This assay was performed 
concurrently with the GMl-ELISA to detect enterotoxin.
12:3(2). Cytotoxin assay
a. Cytotoxin production
Test isolates of C. jejuni were grown on a biphasic 
culture system (Goossens et al., 1985). The solid phase 
consisted of Mueller-Hinton medium (Gibco Laboratories) 
with the liquid phase comprising Medium 199 (Gibco 
Laboratories) with Earle's salts and L-glutamine. The 
plate was incubated at 42°C for 48 hours under micro- 
aerophilic conditions. After incubation, the liquid 
medium was aspirated and centrifuged and the supernatent 
containing the exotoxin was decanted and retained.
b. Toxin assay
Cytotoxin produced by some strains of C. jejuni is 
indicated by destruction of cells in culture systems. 
Filtrates of C. jejuni cultures cause rounding of cells
and death when incubated for 24-48 hours with CHO cell 
monolayers. Cell death was proportional to the 
concentration of toxin present. Toxin production is 
enhanced by culture of C. jejuni in a biphasic system 
comprising Mueller-Hinton medium as the solid phase and 
Medium 199 as the liquid phase.
An aliquot of 0.1 ml of Eagle's Minimum Essential Medium 
(MEM) (Gibco Laboratories) containing approximately 5 X 103 
CHO cells was added to each of the 96 wells of a flat 
bottomed culture plate. The plate was incubated at 37°C 
under 5% carbon dioxide for 18 to 24 hours to facilitate 
fixation of cells. Supernatant containing the exotoxin 
diluted in Medium 199 was then added to the wells in 
aliquots of 0.1 ml. The plate was incubated as before and 
the cells were monitored for 5 days. Cell death indicated 
the presence of exotoxin.
Chapter 13
RESULTS
13:1. Prevalence studies
13:1(1). Prevalence in avian species
Submissions to the Louisiana Veterinary Medical 
Diagnostic Laboratory included commercial chickens, 
backyard Galliformes and exotic and companion species as 
listed in Table 9.
Psittaciformes were most frequently submitted followed 
by Galliformes, Passeriformes and Anseriformes (Table 10).
Of a total of 445 cases examined, C. jejuni was 
isolated from 45 cases (10.1%). The isolation rate was 
highest in August as shown in Figure 5. Birds of the 
order Galliformes yielded the highest isolation rate 
(25.2%) followed by Anseriformes (12.9%) and Columbiformes 
(8.3%) (Table 10). The isolation rate from Falconiformes
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Table 9. Species of birds examined.
ORDER FAMILY SPECIES NUMBER EXAMINED
S truthion i f o r m e s  S t r u t h i o n i d a e  Ostrich (S t ruthio camelus) 1
Pelecaniformes P elecanidae Brown Pelican (Pelec a n u s  o c c i d e n t a l i s ) 2
P h a l a c r o c o r a c i d a e  c o r morant (sp?) 1
Ciconiiformes Ciconi i d a e  S a d d le-billed Stork
(E p h i p p i o r h y n c h u s  asiaticus) 1
S c opidae Hammerhead Stork IScopus  umbretta) 1
T h r e s k i o r n i t h i d a e  Sacred Ibis ( Threskiornis  threskiornis) I
S carlet Ibis (E u d o c i m  r u b e r ) 1
Roseate Spoonbill (Ajaia ajaja) 1
Anser i f o r m e s  Ana t i d a e  domestic swan ( Cygnus olor) 1
Black-necked Swan (Cygnus melanocoryphus) 1
Whooper Swan (Cygnus c y g n u s ) 1
domestic goose (Anser anser) 1
Muscovy Duck ( Cairina moschata) 2
Mood Duck (Aix s p o n s a ) 1
Mandarin duck (Aix galericulata) 3
American Wigeon (Anas a m e r i c a n a ) 3
Gadwall (Anas s t r e p e r a ) 2
Common (Green-winged) Teal
(Anas crecca carolinensis) 3
Mallard (Anas p l a t y r h y n c h o s ) 
w ild A
domestic Mallard 3
d omestic duck 5
domestic runner duck 1
C hinese Spotbill Duck (Anas poecilorhyncha} 
Northern Pintail (Anas a c u t a )
N o rthern Shoveler (Anas clypeata)
F a l c oniformes C a t h a r t i d a e  King Vulture (Sarcoratiphus p a p a )
A c c i p i t r i d a e  Mississippi Kite ( I ctinia n i s s i s s i p p i e n s i s ) 
Bald Eagle {Halia e e t u s  leucocephalus} 
B r oad-winged Hawk (Buteo p l a t y p t e r u s ) 
Red-tailed Hawk ( B u teo j a o a i c e n s i s ) 
hawk (Buteo sp.I 
Golden Eagle (Aquila chrysaetos)
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Table 9 c o n t ’d.
Galliformes C racidae Crested Guan ( P enelope purpurascensj 1
H e l e a g r i d i d a e  Wild Turkey (Heleagris gallopavo] 8
domestic turkey T
P hasianidae Bobwhite Quail ( Colinus virginianus) 32
Chukar Jector/s chukar) 1
Jungle Fowl (Callus gallus) 3
game fowl 44
d o mestic chicken 109
R ing-necked P h easant ( Phasianus c o l c h i c u s ) 6
Red Golden Pheasant (C h r ysolophus pictus) 2
Gray Peacock Pheasant
(Polyplectron bicalcaratum) 1
Common Peafowl (Pavo cristatus) 13
Grui formes Gruidae Sarus Crane (Grus anti gone)
Demoiselle Crane (A n t hropoides virgo)
R allidae A m erican Coot (Fulica atra)
Columbiformes Columbidae Rock Dove (Columba livia) 
Ring-necked Turtle Dove
( S t r eptopelia risoria) 
d o mestic dove 
Mourning Dove I Zenaida m a c r o u r a )
Ps i t t aciformes Loriidae Red Lory (Eos b o r n e a ) 1
R ainbow Lory ( Trichoglossus haematodus) 1
B l a ck-capped Lory ( Lorius lory) 1
lory (sp?) 1
C a c a t u i d a e  Palm C ockatoo ( P r o b o s c i g e r  a t t e r i m ) 1
S a l m o n -crested (Holuccan) Cockatoo
(Cacatua m o l u c c e n s i s) 4
Wh ite (Umbrella) Co c k a t o o  (Cacatua a l b a) 2
C o f f i n ’s Cockatoo ( Cacatua go f f  ini) 2
cockatoo (sp?) 2
Cockatiel (Nysiphicus h o l l a n d i c u s) 45
Psitta c i d a e  Grand Eclectus Parrot
lEclectus roratus roratus) 3
R e d -sided Eclectus Parrot
(E c lectus roratus p o l y c h l o r o s) 4
Budgerigar ( H e l o p s i t t a c u s  undulatus) 57
African Grey Parrot (P s i t t a c u s  eritbacus) 1
Senegal Parrot ( P o i c e p h a l u s  senegalus) 1
Gray-headed (Madagascar) Lovebird
lAgapornis c a n a) 1
1 0 5
Table 9 c o n t ’d.
Psittacidae Peach-faced Lovebird ( A g a pornis r o s e i c o l l i s ) 4
c o n t ’d. Masked Lovebird (Agapornis personata) 1
lovebird (Agapornis sp.) 5
Rose-ringed (Ring-necked) Parakeet
{Psittacula krameri) 3
Green-winged Macaw (Ara chloroptera) 1
Chestnut- f r o n t e d  (Severe) Macaw (Ara several 1
Re d - s houldered (Noble) Macaw (Ara n o b i l i s ) 1
macaw (Ara sp.) 2
Mitred Conure (Aratinga mitrata) 1
W h i t e-eyed Conure (Ar a t i n g a  leucophthalmus) 1
Jandaya (Jenday) Conure (Aratinga jandaya) 1
Black-hooded (Nanday) Conure
(Nandayus nanday) 3
conure (sp?) 2
Honk (Quaker) Parakeet ( Hyiopsitta monachus) 2
White- f r o n t e d  (Spectacled) Amazon
(Amazona a l b i f r o n s ) 2
Red-lored Amazon (Amazona autumnalis) 3
Blue-fronted Amazon (Amazona a e s t i v a ) 3
Yello w - c r o w n e d  Amazon (Amazona ochrocephaJa) 2
Y e llow-naped Amazon
(Amazona ochroc e p h a l a  auropalliata) 2
Double Y e l l o w - h e a d e d  Amazon
(Amazona ochroc e p h a l a  oratrix) 5
Or a n ge-winged Amazon (Amazona a m a z o n i c a ) 1
Blue-crowned Mealy Parrot
(Amazona farinosa guatemalae) 1
Amazon Parrot (Amazona sp.) 5
parrot (sp?) 2
Musop h a g i f o r m e s  Husoph a g i d a e  Guinea Turaco ( Tauraco persa) 2
St rigiformes S t r igidae Eastern Screech Owl (Otus a s i o ) 1
Great Horned Owl (Bubo v i r g i n i a n u s ) 1
Barred Owl (Strix v a r i a ) 4
owl (unknown) 1
Piciformes R h a m p h a s t i d a e  toucan sp. (unknown) 1
P a s s eriformes F r i n g i 1 1 idae Common Canary ( Serinus c a n a r i a ) 22
Yello w - f r o n t e d  Canary (Ser i n u s  mozambicus) 2 
House Sparrow (Passer  donesticus) 1
Es t r i l d i d a e  Zebra Finch (Poephila g u t t a t a ) 3
unknown finch (unknown) 4
1 0 6
Sturnidae
C o rvidae
Table 9 c o n t ’d.
Common S tarling (Sturnus v u l g a r i s ) 1
Blue Jay (Cyanocitta c r i s t a t a ) 1
Table 10. Isolation 
of avian
of C. 
species
jejuni from different orders
Orde rs
Submissions
# %
C. jejuni 
#
isolation
a
"O
Psittaciformes 179 40 . 2 1 0.6
Galliformes 151 33.9 38 25.2
Passeriformes 36 8 .1 0 0-0
Anse ri formes 31 7 . 0 4 12.9
Falconi fo rmes 13 2.9 1 7.7
Columbi formes 12 2 . 7 1 8 . 3
Strigiformes 7 1.6 0 0.0
Ciconiiformes 5 1.1 0 0.0
Grui formes 4 0.9 0 0.0
Pelecaniformes 3 0.7 0 0.0
Musophagi formes 2 0.5 0 0 . 0
Pici formes 1 0 . 2 0 0.0
Struthioni formes 1 0.2 0 0.0
Total 445 100.0 45 10.1
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Figure 5: Seasonal variation in isolation of C. jejuni
from avian species.
was 7.7% and less than 1% from Psittaciformes. 
Campylobacter jejuni was not isolated from Passeriformes 
nor from other miscellaneous birds which were examined. 
Despite the larger number of submissions from the order 
Psittaciformes compared to Galliformes, the isolation rate 
from the companion Psittacines was only 0.6% compared to 
25.2% from the various types of poultry.
A total of 93 Anseriformes, including specimens 
derived from wildlife sanctuaries, were examined during 
the period of the study (Table 11). Campylobacter jejuni 
was isolated from 5 of the waterfowl yielding an isolation 
rate of 5.3%.
Death was attributed to various etiologic factors in 
cases from which C. jejuni was isolated. No mortality 
could be ascribed to campylobacteriosis (Table 12). Cases 
with endoparasitism as the diagnosed cause of death 
yielded the highest (64.7%) isolation rate of C. jejuni 
followed by cases with fungal infection (24.1). Other 
cases yielded relatively lower isolation rates.
Table 11. Isolation of C . jejuni from waterfowl
Species Tested C. jejuni +ve
Duck (Anas platyrhynchos) 29 4
Teal (Anas crecca carolinensis) 28 0
Gadwall (Anas strepera) 2 2 0
Pintail (Anas acuta) 6 0
Wigeon (Anas americana) 3 1
Shoveller (Anas clypeata) 1 0
Goose (Anser anser) 1 0
Swan (Cygnus olor) 2 0
Total 93 5
Table 12. Etiological diagnosis in avian species 
yielding C. jejuni
Disease condition C. jejuni +ve/ %
# examined
Endoparasitism 11/17 64.7
Fungal infection 7/29 24.1
Protozoan infection 3/19 15.8
Toxicity 2/18 1 1 . 1
Trauma 2 / 2 1 9.5
Nutritional deficiency
and starvation 2/25 8 . 0
Viral infection 4/59 6 . 8
Bacterial infection 7/113 6 . 2
Others (Undiagnosed) 7/14 4 4.8
Total 45/445
13:1(2). Prevalence in humans
Fecal specimens from 1423 human diarrheic patients were 
examined for C. jejuni during the period August 1987 
through July 1988. Clinical symptoms in these patients 
ranged from watery diarrhea to more severe enteritis with 
bloody, mucoid stools, abdominal pain and pyrexia. 
Campylobacter jejuni was isolated from 38 patients 
yielding a prevalence rate of 2.7%. Of these isolates, 3 
could not be propogated subsequent to initial isolation 
and identification.
A  seasonal fluctuation in prevalence of campylobacter- 
iosis was noted with a sharp increase in frequency of 
isolation during the summer of 1988 and a smaller peak 
during the winter of 1987 (Figure 6 ). Monthly breakdown 
of the number of fecal samples examined and the number 
yielding C. jejuni and Salmonella spp. during the period 
of study are depicted in Table 13.
The age of patients ranged from 2 to 50 years. A high 
prevalence was observed in children under 5 years, and in 
adults aged 21 to 25 and 31 to 40 years (Figure 7). Both
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Figure 6: Seasonal variation in isolation of C^_ jejuni
and Salmonella spp. from human patients.
Table 13 : Isolation of C. jejuni and Salmonella spp.
from human diarrheic patients
Month # of fecals C. jejuni Salmonella spp.
examined +ve % +ve %
87 Aug 109 1 0.9 7 6.4
Sep 1 0 2 3 2.9 4 3.9
Oct 97 2 2 . 1 2 2 . 1
Nov 108 3 2 . 8 1 0.9
Dec 105 5 4.8 1 1 . 0
8 8 Jan 129 2 1 . 6 4 3.1
Feb 126 2 1 . 6 2 1 . 6
Mar 148 2 1. 4 1 0.7
Apr 109 1 0.9 2 1 . 8
May 141 3 2 . 1 2 1.4
Jun 1 1 1 1 0 9.0 2 1 . 8
Jul 138 4 2.9 1 0.7
Total 1423 28 2.7 29 2 . 0
PERCENTAGE
30
AGE GROUP (in years)
Figure 7. Age distribution of human patients with 
campylobacteriosis.
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sexes were evenly represented in the sample (52% males, 
48% females).
Prevalence of Salmonella spp. during the study period 
was 2.0%. A peak occured in fall of 1987 and the 
isolation rate declined thereafter.
1 3:2 . Serotyping
Antibody titers of antisera prepared against 16
reference strains of C. jejuni are depicted in Table 14.
Except for antiserum 25, all had titers of 1:320 and 
above.
Table 15 depicts the serotype distribution among human 
and avian isolates.
Serotypes 4, 5 and 10 were most prevalent among the
isolates from humans, while serotypes 1, 4 and 16 were
most common among avian isolates. Serotypes 2, 3, 4, 5,
10, 16, 34 and 36 were common among both human and avian 
isolates, of which serotypes 2, 4, 5 and 16, were
isolated in decreasing frequency.
Serotypes 18 and 28 were obtained only from humans
while serotypes 1, 21 and 49 were isolated from avian
species. Serotypes 25, 37 and 56 were not identified in
either humans, or avian species. Figure 8 compares the 
frequency of isolation of serotypes of C. jejuni from 
humans and avian species.
Table 14 : Homologous and heterologous reactions of C. jejuni
serotyping antisera
Titers of serotyping antisera against C.jejuni reference strains
Ref. 1 2 3 4 5 10 16 18 21 25 28 34 36 37 49 56
str .
1 3 2 0 - - -  - -  - -  - -  - -  - -  - -
2 - 640 - - -  - -  - -  - -  - -  - -  -
3 _ _  640 - - -  - -  - -  - -  - -  - -
4 _ _ _  640 - - -  - -  - -  - -  - -  -
5 _ 1280 - - -  - -  - -  - -  - -  
10 _ _ _ _ _  1280 - - -  - -  - -  - -  -
16 _ _ _ _ _ _  3 2 0 - - - - - - - -  -
18 _ _ _ _ _ _ _  640 - - -  - -  - -  -
21 _ _ _ _ _ _ _ _  640 - - - - - - -
25 _ _ _ _ _ _ _ _ _  >160 - - - - - -
28 _ _ _ _ _ _ _ _ _ _  3 2 0 - - - - -
34 _ _ _ _ _ _ _ _ _ _ _  640 - - - -
36 - > 3 2 0 - - -
37 _ _ _ _ _ _ _ _ _ _ _ _ _  640 - -
49 - >320 -
56 _ _ _ _ _ _ _ _ _ _ _ _ _ _  _ 640
Table 15. Serotypes of C. jejuni isolated from human 
patients and avian species
Serotype
Prevalence
Human
# %
in
Avian
# %
Total
Prevalence
# %
1 0 0 . 0 1 0 2 2 . 2 1 0 13.3
2 2 6.7 5 1 1 . 1 7 9.3
3 2 6.7 1 2 . 2 3 4.0
4 5 16.7 6 13.3 11 14.7
5 6 2 0 . 0 3 6.7 9 1 2 . 0
1 0 6 2 0 . 0 1 2 . 2 7 9.3
16 3 1 0 . 0 6 13 . 3 9 1 2 . 0
18 2 6.7 0 0 . 0 2 2.7
2 1 0 0 . 0 2 4.5 2 2.7
28 1 3.3 0 0 . 0 1 1.3
34 1 3.3 2 4.5 3 4.0
36 1 3.3 4 8.9 5 6.7
49 0 0 . 0 1 2 . 2 1 1.3
UT 1 3.3 4 8.9 5 6.7
Total 30 100.0 45 100.0 75 100.0
UT : Untypable
Avian Human
22.2%
Serotype
1 | 0 .0 %
1 1 .1 % 2 | 6.7%
2.2% 3 1 6.7%
13.3% 4 1 16
6.7% 5 1
2 .2 % 10 |
13 . 3% 16 | 10%
0 .0 % 18 | 6.7%
4.5% 2 1 1 0 .0 %
0 .0 % 28 | 3 . 3%
4 . 5% 34 | 3 .3%
8.9% 36 | 3 . 3%
2.2% __ 49 | 0 .0 %
8.9% UT | 3 .3%
20%
20%
UT : Untypable
Figure 8 . Comparison of C. jejuni serotypes isolated 
from human patients and avian species
Among the avian isolates, 60% belonged to serotypes 1, 
2, 4 and 16. Serotypes 4, 5, 10 and 16 constituted 67% of 
human isolates.
13:3. Toxigenicity study
Each determination of GMl ELISA titer represented a mean 
of 9 wells and the procedure was repeated twice to
minimize experimental error. Similarly each CHO cell
assay represented the mean of counts from 4 wells and was 
repeated twice to ensure consistency. The sensitivity of 
GMl ELISA and CHO cell assay was comparable and the 
results were complimentary in determining the toxigenicity 
of C. jejuni isolates.
Enterotoxin production was detected in 53% of human and 
49% of avian isolates. Cytotoxin production was detected 
in 49% of human and 62% of avian isolates (Table 16).
Both enterotoxin and cytotoxin were produced by 28% of
human and 29% of avian isolates. Neither factor was
Table 16. Enterotoxin and cytotoxin produced by C. jejuni 
isolates derived from either human patients or 
avian species
Type of toxin # of isolates Toxin +ve %
Avian
Enterotoxin 45 22 49
Cytotoxin 45 28 62
Human
Enterotoxin 87 46 53
Cytotoxin 87 43 49
detected in 25% of human and 18% of avian isolates 
respectively (Figures 9 and 10).
This study showed that 75% of human and 82% of avian 
isolates produced either or both toxins while 25% and 18% 
respectively were non-toxigenic.
Toxin production by the 5 most frequently isolated 
serotypes were compared. Eighty seven percent of isolates 
of serotype 5 produced enterotoxin, 64% of serotype 1 
produced cytotoxin and 64% of serotype 10 produced both 
toxins (Figure 11 and 12).
Production of either toxin was detected in 8 6 % of 
serotypes 4 and 5, 82 % of serotype 10, and 79 % of
serotype 1 .
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Figure 9 : Distribution of toxin-producing C. jejuni
isolates derived from human patients
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C T X  + v e
C T X  - v e
1
28% | 
1
2 2 %
1
25% | 
1
25%
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Figure 10: Distribution of toxin-producing C. jejuni
isolates derived from avian species
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Figure 11. Cytotoxin production by C. jejuni isolates from 
both avian species and human patients.
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Chapter 14
DISCUSSION
14:1. Prevalence in avian species
The present study shows the significance of Galliformes 
as a reservoir of C. jejuni. The prevalence rate of
25.2% is significant compared to other orders. It is
noted however that this study was limited to traumatized 
or diseased birds submitted for necropsy. The assumption 
that the data obtained represents the prevalence of
C. jejuni in the population of commercial, companion and 
free living avian species in Louisiana, is constrained by 
the degree of correspondence between the sample and the
population of birds in the state.
Although Psittacines were submitted for examination in 
relatively large numbers, a prevalence of only 0 .6 % was 
recorded. This suggests that Psittacines do not represent 
a risk of transmission of C. jejuni to human contacts. 
Due to relative isolation and cage housing of these birds, 
an infectious cycle cannot be maintained and C. jejuni 
infection in individual birds is rare. The susceptibility
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of Psittacines to C. jejuni infection in aviaries, 
breeding colonies and quarantine stations should however 
be investigated.
A 12.9% isolation rate from Anseriformes indicates the 
potential for these birds to transmit infection. 
Migratory waterfowl can serve as asymptomatic carriers of 
infection over long distances. It would be of interest to 
study the prevalence of C. jejuni in various migratory and 
non-migratory species and in water.
In the series of birds reviewed, mortality was not 
attributed to C. jejuni infection. Although statistical 
analysis is inappropriate due to biased sampling, the 
results suggest a positive correlation between parasitism 
and C. jejuni isolation. Fungal infections too, show a 
similar positive correlation. Higher isolation rates are 
presumably due to increased colonization of C. jejuni in 
the intestinal tract following alteration in immune status 
attributable to parasitic and fungal infections. Further 
investigation is necessary to substantiate this 
observation.
Backyard Galliformes and other orders function as 
healthy carriers and may represent a potential zoonotic 
risk to owners following contamination of water, 
the environment, home-dressed poultry and eggs.
14:2. Prevalence in humans
The prevalence rate in diarrheic human patients in 
Baton Rouge (2.7%) corresponds to the 2.6% prevalence rate 
recorded in a Texas (Subramanyam et al., 1984). The 
results of this survey represent a basis for subsequent 
epidemiological investigations. It is noted that the 
sampled population is biased since it comprised diarrheic 
patients. The results are not intended to represent the 
prevalence of C. jejuni in the human population of Baton 
Rouge. The information obtained may certainly be used to 
characterize the population of patients with diarrhea and 
gastrointestinal symptoms sufficient to justify 
professional intervention. The socio-economic and 
demographic factors relating to the sampled population may 
differ from patients seeking treatment at charity 
hospitals. The actual prevalence rate for the Louisiana 
population will obviously be lower than the value obtained 
in this study due to the selection of diarheic 
individuals.
Seasonal fluctuation in prevalence was demonstrated in 
the present study. An increase during summer may be 
attributed to warmer temperature but indirect social
factors may include seasonal frequency of picnics and 
barbeques, which are associated with food-borne infection. 
Similar findings were documented in a study conducted by 
Tauxe et al. (1987). The second peak of campylo- 
bacteriosis, demonstrated in the present study, occured 
during December, which may correspond to the November peak 
in the national study conducted by Tauxe et al. (1987).
The winter peak is probably due to social interaction and 
changes in food consumption during November and December 
coinciding with Thanksgiving and Christmas.
High isolation rates recorded in infants is in all 
probability due to perinatal transmission and has been 
documented by other workers (Karmali et al., 1984; Young 
et al., 1985). The increase in prevalence rate noted in
young adults is attributed to lifestyle. Consumption of 
larger quantities of poultry, red meat and seafood 
increases the risk of food-borne infection. Recreational 
and occupational exposure which brings humans into contact 
with animals or animal products is an important factor 
contributing to the higher rate of isolation in the 2 0 to 
40 year age group.
14:3. Serotyping
The Penner system was able to type 91.1% of the
isolates obtained from human patients and 96.7% of avian
isolates using antisera prepared against 16 out of 60 
known reference strains. The 16 serotypes selected had 
previously been shown to occur most frequently in humans 
and animals in North America (Penner et al., 1983; Patton 
et al., 1985). It was not possible to serotype 8.9% of 
human and 3.3% of avian isolates respectively and this may 
be attributed to either isolates cooresponding to one of 
44 other serotypes not included in this study or rough
variants which do not conform to the Penner system.
Fourteen of the 16 serotypes were identified among the 
isolates collected in the study. Serotypes 2, 3, 4, 5,
10, 16, 34 and 36 were common to both avian species and
humans. This indicates the potential for zoonotic
transmission of C. jejuni infection from birds. Serotype 
1 was isolated only from avian species indicating the low 
risk this serotype pose for human infection.
Correspondance was noted between the results in the 
present study and the data of Penner et al. ( 1983) and
Patton et al. (1985) as depicted in Table 17. Comparing 
the frequency of isolation, it is seen that serotypes 2 , 
4, 5 and 16 are amongst the five most common in both the 
CDC sample and this study. Serotype 10 is included among 
the five common isolates in this study but not in the CDC 
sample. Although serotype 1 was not isolated from human 
patients in the Baton Rouge sample, it is within the first 
five in the CDC list of isolates.
Seven out of 35 (20%) human and 8 out of 45 (18%) avian 
isolates respectively reacted to more than one antiserum. 
Antigens 4 and 16 were closely related, appearing in pairs 
4 times. Antigens 2 and 10 were similarly related, 
appearing 3 times. Other combinations included 2(56) 
recorded twice, 3(21,34), 4(2), 10(18), 16(2) and 34(2)
appearing only once.
14:4. Toxigenicity study
A relatively larger proportion of isolates belonging to 
serotypes 5 and 10 produced enterotoxin. Cytotoxin 
production was detected in 64% of both serotypes 1 and 10. 
Consistent production of either toxin was detected in 
serotypes 1, 4, 5 and 10. Since these serotypes are
Table 17 : Most common serotypes of C. jejuni isolated:
Three studies compared
Serotype Toronto1
% prevalence 
Georgia2 Louisiana3
1 10.3 1 0 . 8 13.5
2 14.4 1 0 . 8 9.5
3 7.0 5.1 4.1
4 14.3 12.7 13.5
5 4.0 8.9 1 2 . 2
1 0 - 5.1 9.5
16 - 5.7 1 2 . 2
18 2 . 1 4 . 5 2.7
21 1.9 4.5 2.7
36 - — 6.7
1. Penner et al. (1983), University of Toronto, Canada.
2. Patton et al. (1985), Center for Disease Control,GA.
3. Present study, Louisiana State University.
frequently isolated both from human patients and avian 
species, there is considerable potential for human 
infection with toxigenic strains of C. jejuni.
Toxin was produced by 75% of human and 82% of avian 
isolates. The relative percentages of isolates producing 
toxins, is in conformity with the results of Johnson and 
Lior (1986) who reported that 85% of human and 100% of 
avian isolates were toxigenic. The higher values may be 
due to differences in assessing toxin production iji vitro. 
Morphological changes in 30% of cells was regarded as 
indicative of toxin production compared to a 50% threshold 
in this study.
This study identified the potential for toxigenic 
strains of C. jejuni to infect humans, especially through 
the medium of contaminated poultry.
14:5. General considerations
Since this prevalence study is the first to be 
undertaken in Louisiana, the data may be used as a basis 
for further investigation of the epidemiology of the 
disease. The present study comprises diarrheic patients
in a specific hospital. A detailed study including 
different socio-economic segments of the population and 
healthy individuals should be undertaken to obtain a more 
precise estimate of the prevalence of human infection. A 
more comprehensive prevalence study including larger 
numbers of free living and clinically normal commercial 
flocks would provide an indication of C. jejuni infection 
in avian species.
Serotyping and studies on toxigenicity were undertaken 
to classify C. jejuni isolates and to identify common 
toxigenic serotypes. Procedures to speciate, serotype and 
to determine the toxigenic profile of C. jejuni isolates 
are pivotal to epidemiologic investigations.
Correlation between isolation of C. jejuni and con­
current bacterial, viral and parasitic infections should 
be investigated. This would indicate circumstances under 
which C. jejuni may cause clinical disease in humans.
Since 50% of the isolates examined in this study were 
common to both humans and avian species, there is an 
obvious potential for zoonotic transmission. As 75% of 
all isolates examined produce either enterotoxin or 
cytotoxin, infection of humans may lead to clinical 
campylobacteriosis. in avian species, C. jejuni is
generally apathogenic but most broiler and turkey flocks 
carry one or more serotypes in the intestinal tract. 
Similarly asymptomatic carriers have been demonstrated in 
humans (Rajan and Mathan, 1982). It is therefore suggested 
that factors other than toxins are involved in the 
occurence of clinical disease (Johnson and Lior, 1986). 
Newell et al. (1985) has demonstrated the role of the 
flagellum in colonization of the intestinal mucosa. The 
extent and type of toxin production is a major determinant 
of pathogenisis. The specific conditions under which 
C. jejuni produces cytotoxin and enterotoxin are not 
clearly understood. Since production of toxins jni vitro 
is variable, it is presumed that the complex intraluminal 
conditions existing in the intestinal tract may influence 
pathogenicity.
Isolates derived from water have been shown to be 
avirulent in mice compared to isolates derived from 
clinical cases (Newell et al., 1985). Kazmi (1984) demon­
strated an enhancement of virulence of C. jejuni following 
passage in mice. The mechanism underlying this change is 
not understood but is a reflection of either selection of 
a toxigenic population within the serotype or activation 
of the cellular mechanism for toxin production.
A study conducted in India (Mathan et al., 1984) failed 
to demonstrate any difference in the occurence of 
enterotoxigenic strains among isolates of C. jejuni 
derived from diarrheic and clinically unaffected children. 
In contrast, Klipstein et al. (1985) demonstrated an 
association between cytotoxin production and a clinical 
history of bloody diarrhea and between enterotoxin 
production and watery diarrhea.
The present study identified the most common serotypes 
prevalent in the samples derived from human patients and 
avian diagnostic submissions in Louisiana. Some serotypes 
were demonstrated to be common to both humans and avian 
species. In addition, the ability of some serotypes to 
produce toxins was confirmed. Further investigation is 
needed to define the relative importance of enterotoxins 
and cytotoxins in the pathogenesis of human disease. The 
genetic and environmental effects on production of 
enterotoxins, cytotoxins and virulence factors should be 
examined in relation to the susceptibility of the host and 
the development of immunity. An important consideration 
concerns the reasons why specific serotypes are innocuous 
in the avian reservoir host but are apparently toxigenic 
in humans.
Subsequent investigations should be directed towards 
the following aspects of interaction of C. jejuni with 
host systems:
1. Factors influenzing toxin production, intestinal 
colonization and pathogenecity
2. Whether non-toxin producing strains can be induced 
to produce toxins
3. The role of surface antigens in the activation of 
the immune system of the host
4. Details relating to the mechanism of toxin 
production
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